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Abstract
Motivated by recent work exploring cluster-level confounding in multilevel observational data, we develop methods specically addressing geographic confounding,
which occurs when measured or potentially unmeasured confounding factors vary by
geographic location.

Accounting for this source of confounding achieves spatially-

balanced global estimates of the treatment eect of interest, allowing researchers to
compare individuals as if they were residentially similar and leading to policy decisions that benet patients and areas most in need.

This dissertation consists of

three aims: 1. To develop a hierarchical spatial doubly robust estimator in propensity
score analysis framework; 2. To develop spatial propensity score matching methods
for hierarchical data; 3. To apply spatial propensity score matching to more complex
analyses of spatially varying, zero-inated outcomes. Each of these aims strives to
explore the issue of geographic confounding and contribute to its resolution.

Aim

1 seeks to build upon multilevel propensity score methods through augmentation of
modeling with spatial random eects to create a spatially balanced estimator that
is demonstrated in simulation to exhibit favorable performance under various sample sizes and levels of spatial heterogeneity. Aim 2 seeks to develop methods in a
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propensity score matching framework, allowing for a more complete understanding
of geographic confounding remediation techniques and extensions to additional applications.

Finally, as modeling non-binary, spatially varying outcomes can prove

challenging, Aim 3 seeks to incorporate spatial matching to alleviate geographic imbalance to allow for a minimally confounded analysis. We apply the spatial matching
approach to the analysis of zero-inated count outcomes.
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Chapter 1
Literature Review
1.1 Causal Inference and the Potential Outcomes
Framework
Evidence-based medicine seeks to incorporate cutting edge research in clinical decisions between a patient and a care-provider [1]. In order to contribute strong and
convincing evidence of clinical benet, researchers must strive to be able to attribute observed endpoint dierences in outcome to the given treatment. If patientor system-level dierences related to the outcome exist between treatment groups,
confounding may occur and it thus becomes challenging to determine with condence that it was specically the treatment that elicited, or caused, the eect. It is
this desire to assert causal inference that has elevated randomized controlled trials
(RCTs) to the top of the study evaluation pyramid, considering evidence generated
from studies with this design more sound and convincing than evidence generated
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from other study designs, thus designating RCTs the gold standard of health outcomes research [2]. Randomization seeks to eliminate selection bias. Along with the
concurrent nature of the control group, randomization ensures the balance of covariates, some of which are unmeasured [3]. It has even been stated that randomization
is the only method to control for imbalance with respect to measured and unmeasured factors [4]. Although issues such as bias should be addressed early in the study
design phase and continue to be revisited through analysis, they are often overlooked
in RCTs due to the condence the community has in the study design. For example,
in the acclaimed NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke
trial, dierences in baseline stroke severity between treatment groups prevailed despite randomization [5]. Beyond the context of RCTs, there exist treatments that
are inherently implausible, impossible or unethical to randomize, but that may be
examined in observational studies. It is in observational studies that we must revisit
the issue of confounding.
The potential outcomes framework put forth by Rubin [6] provides the theoretical
foundation of contemporary causal inference. In the setting of clinical trials, let
denote a binary treatment assignment.
potential outcomes:
while if

Y

Z = 0,

then

Y1

and

Y0

is observed and

can be expressed by

Y = Y0

when

E(Y1 ) − E(Y0 ),

Z = 0.

Y0 .

If

Z

Each individual is assumed to have two

Z = 1,

then

Y1

Y1

is observed and

Y0

is unobserved,

is unobserved. [6] The observed response

Y = ZY1 + (1 − Z)Y0 ,

yielding

Y = Y1

when

Z = 1

The average treatment eect (ATE) is dened as

and

∆ =

and, since in a randomized controlled trial the treatment groups

are in theory balanced with respect to all but treatment assignment,
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(Y1 , Y0 )

are

stochastically independent of treatment assignment. In essence, those who did not
receive treatment can serve as the counterfactual observation for those who did, and
vice versa.
The average treatment eect on the treated (ATT) is an alternative estimand of
interest and can be dened as
treatment indicator

Z =1

∆AT T = E(Y1 − Y0 |Z = 1).

Note the condition on

in the case of the ATT that was not present in that of

the ATE. Informally, the ATT is the dierence in outcome between those who were
treated and those who were not for those who actually participated in treatment [7].
In observational studies, it may be more appropriate to discuss exposure rather
than treatment groups; in any case, these groups are not guaranteed to be balanced
on a set of covariates that are also associated with the outcome
of confounding arises.

and hence the issue

When we address confounding and can reasonably infer no

unmeasured confounding is present, we may assume that
independent of treatment assignment

(Y1 , Y0 )⊥⊥Z|X = x

Y

Z

(Y1 , Y0 )

are conditionally

given a vector of covariates

X,

expressed as

[8].

In the special case where the group designation is an immutable characteristic
such as race, it is important to note that the causal inference framework may not
be appropriate since it is impossible to conceive a potential outcome corresponding
to an alternative race designation.

In this setting, Li et al.

average controlled dierence (ACD) as a
The ACD is dened as

[9] propose using the

descriptive estimand analogous to the ATE.

∆ = EX [E(Y |X = x, Z = 1) − E(Y |X = x, Z = 0)],

the outer expectation is taken with respect to the distribution of covariates
the entire population and

x

where

X

is an observed realization of the random variable
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in

X.

The ACD can be viewed as a weighted sum of the expected group dierences formed
within each stratum of

X.

Under the assumption of no unmeasured confounding,

∆

represents a controlled population-average dierence between the two groups.
The ultimate decision among estimating the ATE, ACD or ATT has much to do
with clinical and epidemiological questions of interest; however, statistical consideration must also be attended to. Interpretation of results should coincide with the
estimand the data and analysis support.
Estimation of causal inference has assumptions that include no unmeasured confounding, a positive probability of each individual to receive treatment, and the stable
unit treatment variable assumption (SUTVA) [10]. SUTVA assumes that treatment
eect is uniform and that the treatment of one subject does not aect the outcome
of another. Schwartz et al. [11] reiterate Little and Rubin's [12] classic example of
psychotherapy: SUTVA could be violated if the eectiveness of the therapy varied
among levels of expertise of the therapist or willingness of the patient to participate.
Furthermore, SUTVA could be violated if a treated patient shared his insight with
other patients, thus aecting their outcomes. SUTVA may also be violated in multilevel settings where it is likely that clusters of individuals interact in a way that may
confer benet or harm to a neighbor of the treated individual despite that neighbor
not having been exposed to treatment himself.
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1.2 Propensity Score Analysis
1.2.1 Overview
Propensity score analysis [8] (PSA) lends methodology to address confounding and
under appropriately addressed assumptions, allows the researcher to make causal
inferences in observational studies. The propensity score

e(x) = Pr(Z = 1|X = x),

is the conditional probability of exposure given a set of covariates
assumption of strong ignorability, i.e.

the positivity condition

X

under the

0 < e(x) < 1

and

no unmeasured confounding. Variable selection for the propensity score model (1.1)
is debated in the literature but tends to incorporate baseline covariates, potential
confounders and true confounders [2] but should not include any factor that could
have been aected by treatment assignment (post-treatment) [13]. It has been shown
that there is minimal detriment when including variables not strongly associated with
exposure and a small impact in increased variance estimates when including variables
not strongly associated with the outcome.

It is suggested that analysts suppress

traditional concerns about collinearity and err on the side of inclusion to satisfy
the condition of no unmeasured confounding [13]. Propensity scores are commonly
generated from logistic regression [7]:

logit(ei )

= logit[e(xi )] = logit[Pr(Zi = 1|Xi = xi )] = xTi β, i = 1, . . . , n.

(1.1)

Furthermore, it has been shown that the propensity score acts as a balancing score
to achieve conditional independence of treatment assignment
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Z

as noted above. [8]

Once generated from a model of the form of equation (1.1), propensity scores can be
used in various settings to achieve this balance.

1.2.2 Methods
1.2.2.1 Inverse Probability of Treatment Weighting
Propensity score weighting, commonly referred to as inverse probability of treatment
weighting (IPTW), assigns propensity score based weights to individuals in a sample, thus creating a new sample in which covariates are balanced between exposure
groups. Weights are assigned by

wi =

Zi (1 − Zi )
+
êi
1 − êi

(1.2)

and therefore an IPTW estimator of the ATE [14] is given by

ˆ IP T W

∆

=n

−1

n 
X
Z i Yi

êi

i=1

where

êi

(1 − Zi )Yi
−
1 − êi

denotes the estimated propensity score for subject


(1.3)

i.

Issues in accuracy and stability may arise when estimated propensity scores approach 0 or 1. Stabilizing weights [15] have been suggested as a remedy to this issue
but limit the analyst to estimating the ATT, which is not numerically equivalent to
the ATE in non-randomized studies. Additionally, issues of misspecication of the
propensity score model may deter condence in the estimation of the ATE. If the estimated propensity score is not equal to the true propensity score, the aforementioned
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formula (1.3) will not necessarily estimate

∆

[16]. As a remedy, however, an aug-

mentation of this formula leads to a semi-parametric doubly robust (DR) estimator
[17] of the form

n

1 Xˆ
∆i
N i=1
"
# "
#
Zi Yi (Zi − êi )Ŷi1
(1 − Zi )Yi (Zi − êi )Ŷi0
=
−
−
+
.
êi
êi
1 − êi
1 − êi

ˆ DR =
∆
ˆi
∆

(1.4)

This DR estimator provides a safeguard and has been shown to be a consistent
estimator of the ATE if either the propensity score model or a model for the outcome
is correctly specied.

Ŷi1

and

Ŷi0

are predictions of the potential outcomes under

treatment and control, respectively, generated from a regression model of
and

X.

It should be noted that in the case of

observed while in the case of
estimator

ˆ DR
∆

in proportions

Z = 0, Ŷi1

Z = 1, Ŷi0

E(Y1 ) and p̂0

the case of

µ̂1 − µ̂0

or a dierence

i.e. a risk dierence.

estimates

E(Y0 ).

In the case of

ˆ DR = p̂1 − p̂0
∆

m1 (X, α1 )

e(X, β)

h

p̂1

propensity

and the postulated outcome regression model is

[16].

E

where

p̂1 , and similarly following for

p̂0 , p̂1 estimates the following expression where the postulated

score model is expressed
denoted

Z

is counterfactual and is not observed. The

When the risk dierence is of interest, the estimator
estimates

on

is counterfactual and is not

can be conceptualized as a dierence in means

p̂1 − p̂0 ,

Y

ZY
e(X,β)

−

Z−e(X,β)
m1 (X, α1 )
e(X,β)
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i

=E

h

ZY1
e(X,β)

h

= E Y1 +

= E(Y1 ) + E
and therefore

p̂1

−

i

Z−e(X,β)
m1 (X, α1 )
e(X,β)

Z−e(X,β)
(Y1
e(X,β)

h

i
− m1 (X, α1 ))

Z−e(X,β)
(Y1
e(X,β)

unbiasedly estimates

E(Y1 )

i
− m1 (X, α1 ))

when

E

h

Z−e(X,β)
(Y1
e(X,β)

i
− m1 (X, α1 )) =

0.
When the propensity score model is correct and strong ignorability holds, i.e.

e(X, β) = e(X) = E(Z|X) = E(Z|Y1 , X), but the outcome model is misspecied,
i
h
Z−e(X,β)
(Y
−
Y
)
= 0 through the following set of equait can be shown that E
1
ij1
e(X,β)
tions:

E

h

Z−e(X)
(Y1
e(X)

i
− m1 (X, α1 ))

i
 h
Z−e(X)
= E E e(X) (Y1 − m1 (X, α1 ))|Y1 , X



= E (Y1 − m1 (X, α1 ))E



= E (Y1 −

h

Z−e(X)
|Y1 , X
e(X)

,X)−e(X)
m1 (X, α1 )) E(Z|Y1e(X)





= E (Y1 − m1 (X, α1 )) E(Z|X)−e(X)
e(X)
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i



= E (Y1 −

m1 (X, α1 )) e(X)−e(X)
e(X)



=0

When the outcome model is correct and unconfoundedness holds, i.e.

E(Y |Z = 1, X) = E(Y1 |X),

but the propensity score model is misspecied, it can

once again be demonstrated that

E

=E

h

h

E

h

Z−e(X,β)
(Y1
e(X,β)

Z−e(X,β)
(Y1
e(X,β)

Z−e(X,β)
(Y1
e(X,β)

− E(Y |Z = 1, X))|Z, X

=E

Z−e(X,β)
E
e(X,β)

=E



Z−e(X,β)
(E(Y1 |Z, X)
e(X,β)



i
− Yij1 ) = 0,

as follows:

i
− E(Y |Z = 1, X))



=E

m1 (X, α1 ) =

i


[(Y1 − E(Y |Z = 1, X))|Z, X]

Z−e(X,β)
(E(Y1 |X)
e(X,β)


− E(Y |Z = 1, X))


− E(Y1 |X)) = 0

Using similar arguments, it can be shown that

p̂0

unbiasedly estimates

E(Y0 ) un-

der strong ignorability [16]. It should be noted that when the propensity score and
outcome regression models are both misspecied, the DR estimator oers no protection and the estimates derived from such equations are not likely to be unbiased.
A large-sample approximate standard error of

ˆ DR
∆

n
1 X ˆ
ˆ DR )2 .
s = 2
(∆i − ∆
n i=1
2
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is

(1.5)

Bootstrapping can also be employed to derive the standard error and surrounding
condence interval.

1.2.2.2 Propensity Score Matching
Propensity score matching is a technique that forms matched pairs between exposed
and unexposed subjects based on the similarity of their estimated propensity scores
[2, 8, 18].

As in all PSA, matching techniques require the analyst to rst decide

on the form of the propensity score model and the variables to be included in the
model.

After propensity scores have been generated, the analyst must then make

decisions on the matching strategy: the uniqueness of pairs, number of controls to be
matched to each exposed individual, the matching variable itself (propensity score,
logit of propensity score, etc.), and the rules for designating acceptable matches. In
terms of acceptable match designation, Austin [2] recommends a caliper width equal
to 0.2 times the standard deviation of the logit of the propensity score as a valuable
compromise between preserving match quality and minimizing mean square error
(MSE) of the treatment eect.
Nearest neighbor k:1 matching [19] is implemented by matching treated subjects
with k controls, although k = 1 may be most popular.

This method results in a

balanced sample if the propensity score is correctly specied; however, many controls
may be discarded, resulting in a drastically reduced sample size and restricting the
analyst to estimating the ATT [13].

Matching without replacement marries the

treated and control subjects and precludes the control from further matches, while
matching with replacement allows the control subject to be eligible for participation
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in a new pair. Another distinction is greedy versus optimal matching. Greedy
nearest neighbor matching may appear to be short-sighted as it is only concerned with
the treated subject's best match without considering future matches, while optimal
matching minimizes the dierence in propensity scores in the overall sample, [20]
although there is no strong indication that optimal matching is universally superior
at producing well-matched groups [13].
Optimal full matching [21] is a special case of subclassication and may alleviate
concerns regarding reduction in sample size. Full matching divides the sample into
matched groups that contain at least one treated subject and any positive number
of controls [22]. This method provides the analyst with a strategy to estimate the
ATE in addition to the ATT.
The ATE, as described in detail in the earlier section concerning confounding,
deserves further attention as its specic interpretation should not be conated with
that of the ATT. Based on the amount of overlap in the propensity scores of the
treatment and control groups (i.e.

common support), it may not be feasible to

calculate the ATE even in a full matching setting. When the ratio of control:treated
subjects is high, the technique of k:1 matching allows the analyst to construct the
ATT; however, if the ratio is low, full matching may be necessary [13].

1.2.2.3 Assessing Balance
Propensity score methods should produce a well-balanced weighted or matched sample.

Once propensity scores have been generated via equation (1.1) and decisions

have been made with respect to its utility, assessment in balance can be achieved by
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the calculation of the standardized dierence for means and proportions, respectively
[2].

(x̄treatment − x̄control )
dmean = q 2
2

(1.6)

(streatment +scontrol )
2

dproportion = q

(p̂treatment − p̂control )

(1.7)

(p̂treatment (1−p̂treatment )+p̂control (1−p̂control )
2

Although commonly and inaccurately reported with test statistics and associated
p-values, balance assessment is limited to sample-level description and should not be
subject to uctuations due to sample size reduction, hence the appropriateness of
the standardized dierence [23].
Balance of individual-level covariates may not be sucient to remedy confounding
if patients are clustered and measured or unmeasured confounders are associated with
exposure at the cluster-level [9, 24].

1.2.3 PSA for Multi-Level Data
The DR estimator has recently been extended to multilevel data [9] where data is
comprised of

(Yij , Zij , Xij )

n

for the

j th

subject in the

ith

cluster:

n

i
1 XX
ˆ ij
∆
N i=1 j=1
"
# "
#
Zij Yij
(Zij − êij )Ŷij1
(1 − Zij )Yij (Zij − êij )Ŷij0
=
−
−
+
êij
êij
1 − êij
1 − êij

ˆ DR =
∆
ˆ ij
∆
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(1.8)

In this formula (1.8),

N

=

P

êij

denotes the propensity score for the

ni where ni indicates the sample size of cluster i.

mixed models are used to estimate

eij , Yij0

and

Yij1 ;

(ij)th

individual and

As before, generalized linear

however, in this case random

eects are incorporated to represent between-cluster heterogeneity and account for
unobserved cluster-level confounders. The results of extensive simulations by Li et
al. signal the necessity to incorporate cluster level information in PSA.
Furthermore, Arpino and Mealli have recently extended propensity score matching to the multilevel setting [25].

In their work, they demonstrate that ignoring

cluster assignment has deleterious eects when estimating the ATT.

1.3 Using Spatial Propensity Scores to Address Geographic Confounding
1.3.1 Geographic Confounding
Geographic confounding occurs when measured or unmeasured confounding factors
vary by geographic location.

Regional factors that contribute to geographic con-

founding are those associated with the exposure and associated with the outcome
independently of the exposure and may include access to resources, community support, and policy inuence among others. In observational studies, exposed individuals may be dierentially geographically distributed compared to unexposed individuals. Ignoring this imbalance could lead to biased estimates of the treatment eect
of interest.
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1.3.2 Existing Spatial PSA Methods
Chagas et al. have developed a spatial propensity score matching method to address
regional dierences in sugarcane production in Brazil [26]. This work adopts a parsimonious approach in estimating the spatial propensity score, justied by sensitivity
analysis.

The method incorporates spatial information via spatial autocorrelation

(SAC), spatial autoregressive (SAR) and spatial error models (SEMs). Additionally,
the researchers explore spatial metrics such as distance to prominent landmark and
an indicator for high density production. This work concludes that including spatial
information is crucial to reduce bias.
Bayesian spatial-propensity score matching (BS-PSM) has recently been introduced by Gonzales et al. [27] as an extension of the regional-level spatial propensity
score matching proposed by Chagas et al. BS-PSM maintains the goal of addressing
uncertainty in the propensity score. Methods to address this uncertainty were previously explored in a non-spatial setting [28, 29, 30, 31]; however, Gonzales seeks to
use Bayesian methods for proper standard error adjustment in a spatial setting. Utilizing spatial probit models to construct propensity score estimates, the authors then
form matches based on a nearest neighbor algorithm that imposes a distance caliper
(spatial caliper matching (SCM)) or neighbor requirement (spatial radius matching
(SRM)) to avoid bad matches. Among the matched sample, a spatial average treatment eect (SATE) is estimated. Lastly, methods are applied to an application of
the eect of micronance in Bolivia.
These studies illustrate advances in PSA to incorporate spatial information; however, they conduct region-level analyses, failing to exploit valuable information at the
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subject-level.
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Chapter 2
Proposed Methodology
2.1 Overview
Building upon the recent work in multilevel and spatial PSA, we propose hierarchical
spatial PSA to address geographic confounding, which occurs when measured or
unmeasured confounding factors vary by geographic location. Patient-level covariates
such as age, demographics, and comorbidities are traditional suspects in confounding;
however, moreover, exposed individuals may in fact live in dierent regions than
unexposed individuals.
Propensity score methods can be extended to the hierarchical spatial setting by
incorporating spatial random eects into the propensity score and outcome models:

logit(eij )

where

φ1i

= logit[Pr(Zij = 1|Xij = xij , φ1i )] = xTij β + φ1i ,

(2.1)

is the spatial random eect for region i. Similarly, a logistic spatial model
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for a binary outcome is expressed as

logit[Pr(Yij

where

φ2i

= 1|Zij = zij , Xij = xij , φ2i )] = xTij γ + zij α + φ2i ,

denotes the spatial random eect for region

(2.2)

i in the outcome model.

low for maximal spatial smoothing, we assign the random eects

φ1i

and

φ2i

To al-

intrinsic

conditional autoregressive (ICAR) priors [32] that take the conditional form

φi | φ−i , σ 2 ∼ N

h∼i

where

indicates that region

number of neighbors, and
tial eects,

φ−i .

h

1 X
φh , σ 2 /mi
mi h∼i

!
,

(2.3)

is geographically adjacent to county

i, mi

is the

σ 2 is the conditional variance of φi given the remaining spa-

By way of this smooth spatial process modeling, we acknowledge and

exploit the tendency of neighboring regions to be more similar than non-neighbors
in terms of access to resources, regional policies and environmental conditions. Additionally, we allow for the estimation of region-level eects even when data in that
region is sparse due to the allowance of borrowing information across adjacent
regions.
Following Brook's Lemma [33], the joint distribution for

φ = (φ1 , ..., φn )T

is given

by


1 T
π(φ | σ ) ∝ exp − 2 φ Qφ ,
2σ
2

where
and



Q = M −A is a spatial structure matrix of rank n−1, with M

A

representing an

n×n

adjacency matrix with
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(2.4)

= diag(m1 , . . . , mn )

aii = 0, aih = 1

if

i ∼ h,

and

aih = 0

otherwise. When a xed intercept is included in the model, a sum-to-zero

constraint must be applied to

φ

to ensure an identiable model.

Models 2.1 and 2.2 can now be used to construct a spatial version of the multilevel DR estimator suggested by Li et al. [9]. Such an extension would yield a global
DR estimate between geographically balanced exposure groups. We could now assume ignorability of group assignment conditional on both observed individual-level
covariates and spatial eect

φ1i .

Alternatively, Model 2.1 can be used to generate

propensity scores to be used in the setting of propensity score matching, creating a
spatially balanced matched sample to be analyzed. Subsequently, Model 2.2 can be
constructed using the matched sample, and an estimate of the risk dierence could
be derived using standardization.
In the case where the outcome of interest is not binary, a more complex spatial
model may need to be adopted. Spatial matching can nevertheless be employed to
ensure both patient-level and geographic balance in the resulting matched sample. It
is then possible to derive a minimally biased eect estimate from the outcome model
of choice.

2.2 Motivating Example
2.2.1 Background
Racial disparities in health outcomes persist even today despite decades of focus
on deciphering the underlying causes [34]. For example, evidence consistently shows
that racial minorities have a higher prevalence of diabetes, poorer diabetes outcomes,
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higher risk of complications, and higher mortality rates compared to non-Hispanic
whites [35, 36, 37]. While these disparities can be partially attributed to individuallevel factors such as age, sex, marital status, and comorbidities [38, 39], there has
been no so-called silver bullet. It is plausible that many factors contribute modestly
to observed disparities.

More recent work has focused on the community, demon-

strating that access to healthy food outlets and the availability of community health
resources may also play a role [40, 41]. Therefore, incorporating geographically varying community factors in racial disparities analysis is important; however, some of
these factors may be unmeasured due to lack of data availability or to their conceptual nature. Additionally, race is both an immutable characteristic and a socially
and historically charged construct that has implications beyond phenotypic and biological characteristics. While the analysis of racial disparities must be sensitive and
comprehensive and any conclusion drawn with restraint, researchers should not be
dissuaded from seeking valuable knowledge that could help target vulnerable individuals.

2.2.2 Data Description
In order to study racial disparities in glycemic control, we obtain data for veterans
with type 2 diabetes. Our analysis is based on a sample of 64,022 non-Hispanic Black
(NHB) and non-Hispanic White (NHW) veterans with residential addresses in Alabama, Georgia or South Carolina in scal year (FY) 2014. Geographic boundaries
are dened by the US Census county-level adjacency matrix irrespective of state
membership [42].

This matrix contains

n = 272
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counties and

1528

pairwise adja-

cencies. In order to ascertain the severity of the disparity, we dene poor glycemic
control as indication of one or more hemoglobin A1c (HbA1c) measurements

≥

8 in

FY 2014. Within-county sample sizes range from 5 to 2,409, with a median of 108.
Ten of the 272 counties in the study region have no NHB veterans. Overall, 36.5%
of individuals in the study exhibit poor glycemic control (40.8% for NHBs, 33.2% for
NHWs). We are able to identify potential patient-level confounders and can utilize
indicated county of residence to incorporate geographic information.
To study the disparity in receiving diabetes education visits among type 2 diabetic
veterans with poor glycemic control, we identify a sample of 20,636 NHB (n
and NHW (n

= 11, 359)

patients with a measure of HbA1c

≥

= 9, 277)

8 in FY 2014. Once

again, we restrict the sample to those veterans with residential addresses in Alabama,
Georgia or South Carolina and utilize the same county-level adjacency matrix as in
the study of poor glycemic control. Overall, approximately 13% of the patients in
the sample receive a diabetes care visit following indication of poor control (15.0%
for NHBs, 11.2% for NHWs).
Lastly, in order to assess the disparity in the number of inpatient days within
the VA health care system, we identify veterans with type 2 diabetes and use their
medical records to calculate the number of days spent as an inpatient in a VA facility
in FY 2014. The data consist of observations for 23,533 NHB (n
(n

= 13, 838)

= 9, 695) and NHW

veterans with type 2 diabetes living in Georgia, Alabama and South

Carolina in 2014.

As the scope of the aforementioned studies in racial disparities

among type 2 diabetic veterans has been restricted to the southeastern United States,
we continue to use this geographic region and its associated county-level adjacency
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matrix for this nal study.

2.3 Specic Aims
The following section describes the structure of this research: it is contained in three
separate but contiguous aims. Each aim is designed to stand alone while also complementing the other two. Uniquely, each aim will address an unanswered gap in the
current literature, and cohesively, all three provide health researchers with a method
to address geographic confounding with proof of concept in simulation, demonstration in application, and extension to current and innovative analysis methodology.

2.3.1 Aim 1
•

To demonstrate the detriment of ignoring geographic confounding in causal
inference by conducting simulation studies that reveal the bias, coverage, and
root mean square error of estimates derived from exclusively subject-level models that do not account for geographic cluster

•

To develop a method to ameliorate the aforementioned detriment by incorporating spatial random eects in the propensity score model stage and the
outcome model stage of propensity score analysis and constructing a spatial
doubly robust weighted estimator

•

To examine the properties and performance of the novel methodology by conducting simulation studies that elucidate the bias, coverage, and root mean
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square error of the spatial doubly robust weighted estimator under various
degrees of spatial heterogeneity and per-region sample size

•

To apply the methodology to a clinically relevant application by analyzing
racial disparities in glycemic control, for which a balanced comparison between
groups is desired, and examining the incremental eects of doubly robust estimation and spatial doubly robust estimation compared to an unadjusted estimate

2.3.2 Aim 2
•

To develop methodology to incorporate spatial random eects in a propensity
score matching framework

•

To examine the performance of eect estimation in the spatially matched samples by conducting simulation studies under various degrees of spatial heterogeneity and per-region sample size

•

To evaluate the eects of the inclusion of an outcome model for further regression adjustment compared to an unadjusted eect estimate

•

To apply the methodology to a clinically relevant application by analyzing
racial disparities in the receipt of diabetes education visits for which the ATT
is the desired eect estimate and examining the incremental eects of estimation among a non-spatially matched sample and a spatially matched sample
compared to an unadjusted estimate
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2.3.3 Aim 3
•

To demonstrate the utility of spatial propensity score matching in alternative
analyses

•

To utilize the methodology and conclusions developed in the prior aims to
analyze a zero-inated count outcome

•

To combine spatial propensity score matching with a spatial negative binomial
hurdle outcome model to derive a well-balanced, minimally biased estimate of
clinically relevant ATTs
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Abstract:

Motivated by a study exploring dierences in glycemic control between

non-Hispanic black and non-Hispanic white veterans with type 2 diabetes, we aim to
address a type of confounding that arises in spatially referenced observational studies.
Specically, we develop a spatial doubly robust (DR) propensity score estimator to
reduce bias associated with geographic confounding, which occurs when measured or
unmeasured confounding factors vary by geographic location, leading to imbalanced
group comparisons. We augment the DR estimator with spatial random eects, which
are assigned conditionally autoregressive priors to improve inferences by borrowing
information across neighboring geographic regions. Through a series of simulations,
we show that ignoring spatial variation results in increased absolute bias and mean
squared error, while the spatial DR estimator performs well under various levels
of spatial heterogeneity and moderate sample sizes. In the motivating application,
we construct three global estimates of the risk dierence between race groups: an
unadjusted estimate, a DR estimate that adjusts only for patient-level information,
and a hierarchical spatial DR estimate. Results indicate a gradual reduction in the
risk dierence at each stage, with the inclusion of spatial random eects providing a
20% reduction compared to an estimate that ignores spatial heterogeneity. Smoothed
maps indicate poor glycemic control across Alabama and southern Georgia, areas
comprising the so-called stroke belt. These results suggest the need for communityspecic interventions to target diabetes in geographic areas of greatest need.
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3.1 Introduction
Diabetes is the seventh leading cause of death in the United States and is associated
with a number of adverse health outcomes, including stroke, heart disease, kidney
failure, and amputation [43]. Evidence consistently shows that racial minorities have
a higher prevalence of diabetes, poorer diabetes outcomes, higher risk of complications, and higher mortality rates compared to non-Hispanic whites [35, 36, 37]. These
disparities are explained in part by individual-level factors such as age, sex, marital
status, and comorbidities [38, 39]. However, recent work has found that geographically varying community characteristics, such as access to healthy food outlets or
the availability of community health resources, may also play a role [40, 41]. Given
that racial disparity studies are inherently observational, it is critical to account for
multiple sources of confounding, both at individual and neighborhood levels, in order
to make comparisons between balanced race groups. This is especially relevant in diabetes research, as numerous recent studies have demonstrated associations between
spatially varying confounding factors such as community environment and diabetes
outcomes [44]. To obtain unbiased estimates of racial dierences, it is necessary to
account not only for individual-level confounding, but also

geographic confounding,

which occurs when the confounding factors, whether observed or unobserved, vary
by geographic locations that share resources.

The goal of this paper is to extend

recent methods for multilevel causal inference to obtain minimally biased estimates
of racial disparities in the presence of geographic confounding.
Propensity score analysis [8] (PSA) oers a principled approach to causal inference in observational studies, and has gained increasing traction in health dis-
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parities studies in recent years [9, 45]. PSA is a multi-stage estimation strategy in
which a propensity score model is rst used to estimate the conditional probability
of group assignment (i.e, the propensity score) given a set of covariates. The estimated propensity scores are then used to balance the groups according to important
characteristics.

Finally, an outcome model is t in order to make balanced group

comparisons. Common balancing methods include matching, stratication and inverse probability weighting. The balancing property of the propensity score ensures
similar covariate distributions across groups under mild assumptions, allowing for a
minimally confounded outcome analysis [2]. A particularly attractive weight-based
estimator is the doubly robust (DR) estimator [46], which is a consistent estimator of the average treatment eect when either the propensity score model or the
outcome model is correctly specied. Because racial identity is an immutable characteristic for which we desire a balanced comparison, the term average controlled
dierence is commonly used to denote the estimand of interest in racial disparity
studies [9].
The central aim of this paper is to develop a spatial DR estimator that minimizes
bias in the presence of observed and potentially unobserved geographic confounding.
While there has been some recent work incorporating spatial information into PSA
[26, 27, 47, 48], these methods have been limited to non-clustered data in which the
response variable is a region-level proportion. Arpino and Mealli [25] and Li et al. [9]
recently introduced PSA approaches for multilevel data. They t propensity score
and outcome models that included random eects to account for unobserved clusterlevel confounding. Li et al. [9] additionally compared weighted estimators derived
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from xed and random eects models to demonstrate the benet of incorporating
cluster-level random eects in PSA, as well as the protective properties of the DR
estimator. However, their approach did not incorporate spatial information.
Here, we propose a spatial DR estimator that incorporates available information at both the individual and region levels. We introduce a set of spatial random
eects to account for variation due to unobserved geographic confounders.

The

random eects are assigned conditionally autoregressive (CAR) prior distributions
that promote localized spatial smoothing by borrowing information from surrounding geographic areas. We adopt maximum likelihood (ML) as our initial estimation
approach when tting the spatial propensity score and outcome models. However,
because ML-based numerical integration routines become unstable as the dimension of the random eects increases, we explore two alternative estimation methods:
penalized quasi-likelihood and Bayesian inference. We conduct detailed simulation
studies to compare the inferential properties of the three estimation methods under
varying degrees of spatial heterogeneity. Finally, we apply the method to a study
examining racial disparities in glycemic control among veterans with type 2 diabetes
residing in the southeastern United States.

3.2 Spatial Propensity Score Analysis
3.2.1 Overview of Propensity Score Weighting Methods
We begin by briey reviewing the inferential properties of PSA as outlined in Rosenbaum and Rubin [8] and summarized more recently in Lunceford and Davidian [14].
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Z

Let

Z

denote a group indicator taking values 0 or 1. In the context of clinical trials,

commonly represents an assigned treatment group (e.g.,

control), while in epidemiologic settings,
group. In principle,

Z

Z

Z=1

if treated and 0 if

typically denotes a manipulable exposure

can take more than two values, but since our focus in this

paper is to estimate dierences between only two groups, we assume throughout that

Z

is dichotomous. According to the causal framework outlined by Rubin [6], each

individual is assumed to have two potential outcomes
note the (potentially counterfactual) outcomes under
The observed response,
and

Y = Y0

otherwise.

(Y1 , Y0 ),

where

Y1

and

Y0

de-

Z = 1 and Z = 0, respectively.

Y , is given by Y = ZY1 + (1 − Z)Y0 , so that Y = Y1

if

Z=1

A common causal estimand of interest is the population

average treatment eect (ATE), dened as
only one of

(Y1 , Y0 ),

∆ = E(Y1 ) − E(Y0 ).

unbiased estimation of the ATE,

estimate the average eect conditional on

observed

∆,

Because we observe

requires that we instead

treatment assignment, that is,

∆∗ = E(Y1 |Z = 1) − E(Y0 |Z = 0).
In randomized controlled trials, the treatment groups are balanced with respect
to relevant covariates, ensuring that the potential outcomes
cally independent of the treatment assignment
observed treatment dierence

∆∗

Z.

(Y1 , Y0 )

In this case,

are stochasti-

∆∗ = ∆,

and the

serves as a suitable target for causal inference. In

observational studies, however, the groups are not guaranteed to be balanced, and in
this case we cannot conclude that
sume that

∆∗ = ∆.

Nevertheless, it may be reasonable to as-

(Y1 , Y0 ) are conditionally independent of Z

given a vector of covariates

X.

This is commonly referred to as the no unmeasured confounding assumption [8].
Under this assumption, the ATE can be identied from the observed data
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(Y, Z, X)

through the equation

∆ = E(Y1 ) − E(Y0 )

(3.1)

= EX [E(Y1 |X = x) − E(Y0 |X = x)]
= EX [E(Y1 |X = x, Z = 1) − E(Y0 |X = x, Z = 0)]
= EX [E(Y |X = x, Z = 1) − E(Y |X = x, Z = 0)],

where the outer expectation is taken with respect to the distribution of covariates

X
X.

in the entire population and

x

is an observed realization of the random variable

The third line of equation (3.1) follows from the conditional independence of

(Y1 , Y0 )

and

fact that

Z

under no unmeasured confounding, and the last line follows from the

Yk = Y

if

Z = k (k = 0, 1).

Consequently, causal inference regarding the

ATE can be made using the observed data.
When the treatment variable is an immutable characteristic such as race, the
potential outcomes framework is not strictly applicable, since there is no well-dened
potential outcome corresponding to an alternative race designation. This precludes
formal causal inference in the context of racial disparity studies.

In this setting,

Li et al. [9] propose using the average controlled dierence (ACD) as a

descriptive

estimand analogous to the ATE, where the ACD is dened as

∆ = EX [E(Y |X = x, Z = 1) − E(Y |X = x, Z = 0)].

(3.2)

Because the latter expression is identical to the last line of equation (3.1), we use
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∆

throughout to denote either the ATE and ACD. However, the former is a causal estimand, whereas the latter is a purely descriptive one. When there is no unmeasured
confounding, the ACD represents a population-average dierence between two fully
adjusted comparison groups. Although our focus here is on the ACD, the methods
described below can equally apply to settings where the ATE is a more natural target
of inference.
Under unconfoundedness, propensity score methods can be used to derive unbiased estimators of the ATE or ACD in observational studies. The propensity score,

e(x) = Pr(Z = 1|X = x),

is the conditional probability of exposure given

the so-called overlap condition,
Rubin [8] established that

e(x)

0 < e(x) < 1,

X,

where

is assumed to hold. Rosenbaum and

functions as a balancing score such that



(1 − Z)Y
ZY
−
∆=E
e(x)
1 − e(x)


,

(3.3)

when both the overlap and unconfoundedness assumptions hold. Hence, an unbiased,
Horvitz-Thompson type [49] estimator can be obtained by correctly specifying a
propensity score model. The propensity scores are typically estimated using a logistic
regression model of the form

logit(ei )

= logit[e(xi )] = logit[Pr(Zi = 1|Xi = xi )] = xTi β, i = 1, . . . , n.

(3.4)

If model (3.4) is correctly specied, an unbiased, inverse-probability weight (IPW)
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estimator of the ACD is given by

ˆ IP W = n−1
∆

n 
X
Zi Yi
i=1

where

êi

êi


(1 − Zi )Yi
−
,
1 − êi

denotes the estimated propensity score for subject

(3.5)

i.

To guard against

misspecication of the propensity score model, Robins et al.[17] developed a semiparametric doubly robust (DR) estimator of the form

n

X
ˆ DR = 1
ˆi
∆
∆
n i=1
# "
#
"
(Z
−
ê
)
Ŷ
(Z
−
ê
)
Ŷ
(1
−
Z
)Y
Z
Y
i
i
i1
i
i
i0
i
i
i
i
ˆi =
−
+
−
,
∆
êi
êi
1 − êi
1 − êi
where

Ŷi1

and

Ŷi0

are predicted outcomes obtained by regressing

the former including the regression coecient for

Z

Y

on

X

(3.6)

and

Z,

and the latter excluding it. The

doubly robust property derives from the fact that expression (3.6) is a consistent
estimator of

∆

if either the propensity model or the outcome model is correctly

specied. The large-sample approximate variance of

ˆ DR
∆

n
1 X ˆ
ˆ DR )2 .
s = 2
(∆i − ∆
n i=1
2

is given by

(3.7)

Alternatively, bootstrapping by resampling with replacement can be used to estimate
the standard error and associated condence intervals.
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3.2.2 A Doubly Robust Estimator for Hierarchical Spatial
Data
Li et al.

[9] recently extended the DR estimator to the multilevel setting, where

(Yij , Zij , Xij )

denote the data for the

j -th

subject in cluster

i.

Li et al. propose the

following hierarchical DR estimator of the ACD:

n

n

i
1 XX
ˆ ij
∆
N i=1 j=1
"
# "
#
Zij Yij
(Zij − êij )Ŷij1
(1 − Zij )Yij (Zij − êij )Ŷij0
=
−
,
−
+
êij
êij
1 − êij
1 − êij

ˆ DR =
∆
ˆ ij
∆

where

ni

eij

denotes the propensity score for the

is the sample size of the

to estimate

eij , Yij0 ,

and

i-th

Yij1 ,

(ij)-th

individual,

N =

Pn

i=1

(3.8)

ni ,

and

cluster. Generalized linear mixed models are used
with the random eects accommodating between-

cluster heterogeneity and accounting for smoothly varying, unobserved cluster-level
confounders.

Using simulation studies, Li et al.

demonstrate that incorporating

the random eects yields improved inferences over models that ignore cluster-level
variation or treat the cluster indicators as xed eects. Analogous to equation (3.7),
the large-sample variance estimator of

ˆ DR
∆

is given by

ni
n
1 XX
ˆ ij − ∆
ˆ DR )2 .
s = 2
(∆
N i=1 j=1
2

(3.9)

The multilevel estimator proposed by Li et al. is readily extended to the spatial
setting by augmenting the propensity score and outcome models with spatial random
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eects, resulting in a spatial version of the DR estimator given in equation (3.8).
Turning to our motivating application, let
control for the

j -th individual

Yij

denote the presence of poor glycemic

residing in the i-th county, let

Zij

denote an indicator

variable taking a value of 1 if the individual is non-Hispanic black (NHB) and 0 if
non-Hispanic white (NHW), and let

xij

represent a set of patient-level covariates.

The spatial propensity score model is given by

logit(eij )

where

φ1i

= logit[Pr(Zij = 1|Xij = xij , φ1i )] = xTij β + φ1i ,

is the spatial random eect for county

i.

(3.10)

Similarly, the spatial outcome

model is expressed as

logit[Pr(Yij

where

φ2i

= 1|Zij = zij , Xij = xij , φ2i )] = xTij γ + zij α + φ2i ,

denotes the spatial random eect for county

i

(3.11)

in the outcome model. The

spatial random eects can represent geographic variability in health care access,
availability of community outreach and medical education programs, or access to
other resources that may be associated with both race and diabetes management. To
encourage maximal spatial smoothing, we assign each of the random eects

φ1i

and

φ2i an intrinsic conditional autoregressive (ICAR) prior [32] that takes the conditional
form

φki |
where

h ∼ i

φk(−i) , σk2

∼N

indicates that county

1 X
φkh , σk2 /mi
mi h∼i
h

!
, k = 1, 2,

is a geographic neighbor of county
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(3.12)

i , mi

is

the number of neighbors, and, for model
given the remaining spatial eects,

φk(−i) .

k , σk2

is the conditional variance of

φki

Modeling between-county heterogeneity

via a smooth spatial process is benecial for two reasons.

First, it recognizes the

inherent tendency for neighboring regions to share health resources or experience
similar environmental pressures that can lead to poor health outcomes. Second, it
improves estimation of region-level eects by borrowing information from neighboring
areas, thus reducing uncertainty in estimating the propensity scores and predicting
the potential outcomes used to derive the spatial DR estimator.
Following Brook's Lemma [33], the joint distribution for

φk

=

(φk1 , . . . , φkn )T

is

given by

π(φk |
where
and

σk2 )


1 T
∝ exp − 2 φk Qφk , k = 1, 2,
2σk


(3.13)

Q = M −A is a spatial structure matrix of rank n−1, with M

A

aih = 0

representing an

n×n

adjacency matrix with

= diag(m1 , . . . , mn )

aii = 0, aih = 1

if

i ∼ h,

and

otherwise. When a xed intercept is included in the model, a sum-to-zero

constraint must be applied to

φk

to ensure an identiable model.

3.2.3 Model Fitting and Inference
Because the DR estimator is a frequentist estimator, we adopt maximum likelihood as our default estimation approach.

Maximum likelihood for models (3.10)

and (3.11) can be easily implemented using o-the-shelf software such as SAS

GLIMMIX

[50].

Maximum likelihood is selected by specifying the

PROC

METHOD=QUAD

op-

tion, which combines adaptive Gauss-Hermite quadrature for numerical integration
with Newton-Raphson routines for maximization. The spatial covariance matrix is
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introduced by rst computing the Moore-Penrose generalized inverse of the structure
matrix

Q

in expression (4.4), and then incorporating this as part of a user-dened

PROC GLIMMIX.

covariance matrix in

Details can be found in Rasmussen [51]. The

Moore-Penrose inverse is unique and serves the dual purpose of imposing the identiability restriction

Pn

i=1

φi = 0.

Although adaptive quadrature tends to work well

for low-dimensional random eects models (e.g., random intercept models), it becomes computationally burdensome as the dimension of the random eects grows,
since an increasing number of quadrature points is required to accurately estimate
the multivariate random eect distribution. For example, adaptive quadrature can
pose challenges for models that include spatially varying covariates.
To address this potential limitation, we consider two computationally tractable
estimation strategies: penalized quasi-likelihood (PQL) and Bayesian inference. PQL
[52, 53] is an iterative estimation procedure achieved through Taylor series expansions
of the response about current estimates of the xed and random eects [54]. The
expansion yields a pseudo-response that is linear in the model parameters. A linear
mixed model is then t to the pseudo-response using restricted maximum likelihood,
thus avoiding computationally challenging numerical integration routines. PQL for
the spatial propensity score and outcome models can be t in
default

METHOD=RSPL

PROC GLIMMIX using the

option for restricted pseudo-maximum likelihood estimation.

Finally, we consider Bayesian estimation, the most common inferential approach
for tting spatial CAR models. Here, the propensity score and outcome models are
estimated separately using approximate Bayesian methods. The propensity score

eij

is estimated using the posterior mean of the linear predictors from the propensity

43

score model given in equation (3.10). Likewise, the potential outcomes

Ŷij1

and

Ŷij0

are estimated (or, more accurately, predicted) using the posterior mean linear predictors from the outcome model, the former including the posterior mean for

α

in

equation (3.11) and the latter excluding it. The resulting estimates and predictions
are fed into the spatial DR estimator for nal inferences. In this context, the Bayesian
approach should be viewed simply as an alternative way to estimate the propensity
score

eij

and predict the potential outcomes

Yij0

and

Yij1

when forming the DR es-

timator. The DR estimator itself is a large-sample frequentist estimator, and hence
our overall inferential approach should once again be regarded as frequentist.

By

tting separate propensity score and outcome models, we avoid the so-called feedback issue that can arise when the models are tted jointly under a fully Bayesian
approach [55]. For our application, we adopt the ecient integrated nested Laplace
approximation (INLA) proposed by Rue et al. [56]. INLA uses a Laplace approximation to estimate the joint posterior of the model parameters, yielding improved
computational capacity over standard Markov chain Monte Carlo routines.
method can be easily implemented in the R package
the

Besag

INLA

This

(www.r-inla.org), where

option is used to specify the ICAR prior. As a default, we assign weakly

informative N(0, 1e5) priors to xed eects and Ga(1, 5e-05) priors for the spatial
precision (i.e., inverse variance) terms, where Ga(a, b) denotes a gamma distribution
with shape parameter

a

and rate parameter

b.

To investigate sensitivity to prior

specication, in our case study we consider alternate priors per the recommendation
of Carroll et al. [57] for the regression coecients and spatial variances. Alternative
prior specications are discussed in Section 3.4.
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3.3 Simulation Study
3.3.1 Data Description
To examine the performance of the proposed spatial DR estimator, we conduct a
series of simulation studies. The goals were to 1) examine the inferential properties
(e.g., bias, 95% coverage) of the proposed spatial DR estimator under varying sample
sizes and degrees of spatial heterogeneity; 2) explore the impact of ignoring spatial
heterogeneity during model tting; and 3) compare the performance of the three
estimation strategies described in the previous section. Additionally, we conducted a
sub-study to assess the ability of the spatial DR estimator to capture the true ACD
when important spatially varying covariates were ignored during model tting. To
emulate the geographic structure in our application, we used the US Census countylevel adjacency matrix for South Carolina, Georgia, and Alabama [42]. This matrix
contains

n = 272

counties and

1528

pairwise adjacencies. For the primary study, we

generated 100 datasets from the following propensity score and outcome models:

logit[Pr(Zij
logit[Pr(Yij

= 1|Xij = xij , φ1i )] = β0 + xij β1 + φ1i

(3.14)

= 1|Zij = zij , Xij = xij , φ2i )] = γ0 + xij γ1 + zij α + φ2i ,

(3.15)

i = 1, . . . , 272; j = 1, . . . , ni ,

where

Xij

was simulated according to a N(5, 2) distribution; the xed eect coe-

cients were set at

β0

= 0.25,

β1

= -0.15,

γ0

= 0.35,

γ1

was allowed to take on three values: 25, 50, and 100; and
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= -0.50, and

φ1i

and

φ2i

α

= 0.90;

ni

were simulated

from ICAR models given in equation (4.4) with

2
σφ1

and

2
σφ2

each taking values 1, 4,

and 9 to represent increasing degrees of spatial variation. These parameter values
yielded an average risk dierence of approximately 0.10, which follows the existing
literature on disparities in glycemic control [58]. We also examined scenarios where
both of the above models excluded spatial eects, in order to examine the behavior
of the spatial DR estimator when the data exhibited no spatial heterogeneity.
To accomplish the aim of our sub-study, we augmented the models in equations
(3.14) and (3.16) to include a county-level covariate generated according to a N(10, 3)
distribution and an additional spatially smoothed county-level covariate simulated
according to the ICAR model given in equation (4.4), with
= -0.1 and

β3

σ 2 = 2 and coecients β2

= 0.1 for the respective spatially varying covariates in the propensity

score model and

γ2

= 0.3 and

γ3

= -0.3 for the respective spatially varying covari-

ates in the outcome model. Spatial variances for

φ1i

and

φ2i

were each set to the

intermediate level of 4.

3.3.2 Results
Table 3.1 summarizes the performance of the spatial DR estimator when the data
were generated according to the random intercept propensity score and outcome
models given in equations (3.14) and (3.16).

Rows indicate the varying levels of

2
spatial heterogeneity (σφ ) and sample sizes (ni ) used to generate the data, including
2
the case where the simulated data contained no spatial heterogeneity (σφ

= 0).

Columns delineate the mean absolute bias, RMSE, and 95% coverage of the estimated
ACDs under the three estimation strategies.
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Several trends emerge from the simulations.

First, when the generated data

contained no spatial heterogeneity, the spatial DR estimator performed well, with
negligible bias, low RMSE, and near nominal coverage.

100

For example, when

ni =

and maximum likelihood estimation was used, the bias under the spatial DR

estimator was 0.003, with 95% coverage equal to 0.97. These trends continued even
as the sample size decreased. Under

ni = 25, for instance, the bias ranged from 0.007

to 0.008 across the three estimation approaches.
Second, as the spatial heterogeneity in the data increased, the spatial DR estimator continued to perform well, whereas the non-spatial estimator displayed increasingly poor performance. For example, under maximum likelihood, the 95% coverage
for the spatial model was 0.96 when
and

σφ2 = 9.

ni = 100

and

σφ2 = 1,

and 0.92 when

ni = 100

In contrast, the non-spatial models showed poor coverage whenever

spatial heterogeneity was present. For example, with

ni = 100,

the coverage under

maximum likelihood for the non-spatial estimator decreased from 0.57 when
and to 0.16 when

σφ2 = 9.

σφ2 = 1

As sample size decreased, bias and RMSE of the spatial

DR estimator increased but remained favorable, particularly in contrast to the nonspatial DR estimator. The coverage of the DR estimator also remained near nominal
levels as

σφ2 = 9,

ni

decreased, except in the most extreme scenario in which

ni = 25

and

where the coverage under maximum likelihood fell to 0.85. However, this

was vastly higher than the 0.24 coverage observed for the non-spatial estimator.
Table 3.2 demonstrates the doubly robust property of the spatial DR estimator.
As in Table 3.1, rows delineate varying degrees of spatial heterogeneity and county
sample sizes.

Columns indicate which of the two models, the propensity score or
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the outcome model, was misspecied by excluding a spatial random intercept.

In

general, correctly specifying either the spatial propensity score or outcome model
resulted in low bias and RMSE, conrming the doubly robust property of the proposed estimator. Not surprisingly, as the spatial heterogeneity increased to extreme
levels (e.g.,

σφ2 = 9),

misspecifying one of the models led to modest increases in

bias and RMSE. These increases were more prominent when the outcome model
was misspecied, a result consistent with previous work suggesting more deleterious
consequences for misspecifying the outcome model rather than the propensity score
model in hierarchical settings [9].
Across all scenarios, the three estimation strategies yielded similar results, suggesting that any of the three approaches can be adopted in practice. However, if a
secondary aim is to explore spatial heterogeneity in the outcome model, our experience suggests that INLA yields smoother and indeed more accurate predictions of
spatial eects (e.g.,

φ2i

in equation (3.11)) than the other two estimation methods.

Thus, if a subsequent goal is spatial prediction, as in our application, we recommend
working with INLA throughout, or, alternatively, using a frequentist procedure to estimate the ACD and Bayesian methods for spatial prediction in subsequent analyses
involving the outcome model.
Table 3.3 presents results of the sub-study using INLA to estimate the propensity
score and outcome models. The goal of the sub-study was to assess the ability of
the proposed spatial doubly robust estimator to capture the true ACD when relevant
county-level covariates were left out of the analysis. The non-spatial analysis ignored
space entirely, whereas the intermediate spatial analysis included a spatial random
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eect in both the propensity score and outcome models yet treated the spatially
varying covariates as unmeasured. The benchmark analysis t the true models that
included both the spatial random eects and the spatially varying county-level covariates. As Table 3.3 indicates, the non-spatial analysis performed poorly, whereas the
spatial analysis that included only random intercepts retained favorable properties
across all scenarios, including low bias, low RMSE and near-nominal coverage. As
expected, we observed good performance under the benchmark analysis that included
the xed county-level covariates in addition to the spatial intercepts. Overall, there
does not appear to be much dierence between the spatial and benchmark models.
These results support the use of the proposed spatial DR estimator, as it appears
to capture the true risk dierence even when county-level xed eects are ignored
during model tting. As it is not uncommon for these covariates to be unavailable
to the analyst, the spatial DR estimator provides a practically useful strategy to
account for unmeasured geographic confounding.

3.4 Analysis of Racial Disparities in Glycemic Control
Our work was motivated by a study examining racial disparities in glycemic control
among veterans with type 2 diabetes.

The goal of the study was two-fold:

rst,

to estimate racial disparities in poor glycemic control while accounting for relevant
patient information and spatial variation; and second, to identify counties with high
rates of poor glycemic control across the study region. Our analysis was based on
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Simulation results for random intercept models:

Mean bias, RMSE, and 95% coverage of the

0.009
0.027
0.044

2
σφ
=1

=4

2
σφ

2
σφ
=9

0.011
0.029
0.049

=1

2
σφ

2
σφ
=4

2
σφ

0.029
0.061

=4

2
σφ

2
σφ
=9

3

2

C3

0.077 24

0.037 40

0.014 83

0.009 95

0.067 17

0.040 39

0.014 76

0.007 96

0.057 16

0.035 24

0.013 57

0.004 97

R2

0.010

0.008

0.008

0.007

0.008

0.007

0.005

0.005

0.005

0.004

0.004

C3

0.013 85

0.011 92

0.010 94

0.009 95

0.009 91

0.008 94

0.007 96

0.007 97

0.007 92

0.005 96

0.005 96

0.004 97

R2

Spatial

0.003

B1

Mean absolute bias
Root mean squared error (RMSE)
95% coverage

0.011

2
σφ
=1

1

0.007

2
σφ
=0

ni = 25

=9

0.005

2
σφ
=0

ni = 50

0.003

2
σφ
=0

ni = 100

B1

Non-spatial

Maximum Likelihood

excluded spatial eects in both models.

0.048

0.029

0.011

0.007

0.049

0.029

0.010

0.005

0.044

0.027

0.009

0.003

B1

C3

0.060 26

0.037 40

0.014 83

0.009 95

0.067 17

0.040 39

0.014 76

0.007 96

0.057 16

0.035 24

0.013 57

0.004 97

R2

Non-spatial

0.010

0.008

0.008

0.007

0.008

0.007

0.005

0.005

0.005

0.004

0.004

C3

0.013 85

0.011 91

0.010 93

0.009 96

0.009 91

0.008 94

0.007 96

0.007 97

0.007 92

0.005 96

0.005 96

0.004 97

R2

Spatial

0.003

B1

Penalized Quasi-likelihood

0.045

0.029

0.013

0.008

0.044

0.027

0.010

0.006

0.048

0.029

0.011

0.004

B1

C3

0.057 30

0.036 42

0.016 77

0.010 92

0.055 20

0.034 33

0.013 76

0.007 96

0.063 14

0.039 26

0.014 57

0.004 98

R2

Non-spatial

0.010

0.011

0.009

0.008

0.008

0.007

0.006

0.005

0.005

0.005

0.004

C3

0.012 83

0.013 85

0.011 89

0.010 93

0.009 93

0.009 87

0.007 92

0.007 92

0.007 94

0.007 93

0.006 89

0.005 97

R2

Spatial

0.004

B1

Bayesian

Spatial models included random intercepts in both the propensity score and outcome models; non-spatial

non-spatial and spatial DR estimators under various sample sizes, spatial variances, and estimation methods.

Table 3.1:
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=9

2
σφ

=9

2
σφ

0.012

2
σφ
=9

3

2

1

‡

0.014

0.013

0.010

0.009

0.009

0.007

0.006

0.005

0.005

R2

75

86

91

83

85

91

83

94

93

C3

0.021

0.012

0.008

0.014

0.009

0.006

0.009

0.006

0.004

B1

C3

0.026 65

0.016 82

0.010 91

0.019 72

0.011 84

0.007 94

0.012 83

0.007 92

0.005 95

R2

Outcome‡

0.012

0.009

0.008

0.007

0.007

0.006

0.005

0.004

0.004

B1

0.014

0.013

0.010

0.009

0.008

0.007

0.006

0.005

0.005

R2

75

86

91

83

84

91

83

94

93

C3

Propensity Score

0.021

0.012

0.008

0.014

0.009

0.006

0.009

0.006

0.004

B1

C3

0.026 65

0.016 82

0.010 91

0.020 72

0.011 84

0.007 94

0.012 83

0.007 92

0.005 95

R2

Outcome

Penalized Quasi-likelihood

0.009

0.009

0.008

0.007

0.007

0.006

0.005

0.005

0.004

B1

0.012

0.011

0.010

0.008

0.009

0.008

0.007

0.006

0.005

R2

86

81

95

86

88

91

77

82

95

C3

Propensity Score

0.018

0.010

0.008

0.012

0.008

0.006

0.010

0.006

0.004

C3

0.024 72

0.013 93

0.010 97

0.015 82

0.009 96

0.008 90

0.012 77

0.007 94

0.005 96

R2

Outcome
B1

Bayesian

Propensity score model (3.14) misspecied (no random intercept), outcome model (3.16) correctly specied.
Outcome model (3.16) misspecied (no random intercept), propensity score model (3.14) correctly specied.
Mean absolute bias
Root mean squared error (RMSE)
95% coverage

0.009

=4

2
σφ

†

0.008

2
σφ
=1

ni = 25

0.007

=4

2
σφ

0.007

0.006

2
σφ
=1

ni = 50

0.004

=4

2
σφ

0.005

0.004

2
σφ
=1

ni = 100

B1

Propensity Score†

Maximum Likelihood

sample sizes, spatial variances, and estimation methods. Columns indicate which model was misspecied.

Table 3.2: Mean bias, RMSE, and 95% coverage of the partially misspecied DR estimators under various

Table 3.3: Results for the sub-study: Mean bias, RMSE, and 95% coverage of the
non-spatial, spatial, and benchmark doubly robust estimators under various sample
sizes. The spatial DR estimator included a spatial random intercept in the propensity score and outcome models but ignored the spatially varying covariates.

The

benchmark DR estimator incorporated the spatially varying covariates in addition
to the spatial random intercept in the propensity score and outcome models.

Sample size
ni
ni
ni

Non-spatial

Spatial

Benchmark

Bias

RMSE

Coverage

Bias

RMSE

Coverage

Bias

RMSE

Coverage

= 100

0.032

0.044

24

0.006

0.011

90

0.006

0.013

91

= 50

0.034

0.049

31

0.007

0.008

93

0.006

0.008

93

= 25

0.031

0.046
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0.010

0.020

88

0.010

0.018

85

a sample of 64 022 NHB and NHW veterans with residential addresses in Alabama,
Georgia or South Carolina. Poor glycemic control was dened as having at least one
hemoglobin A1c (HbA1c) measurement

≥

8 in scal year 2014. Study details have

been reported elsewhere [59]; here, we summarize key features of the data. Withincounty sample sizes ranged from 5 to 2409, with a median of 108. Ten of the 272
counties in the study region had no NHB veterans. This does not pose a problem for
estimating the county-level spatial eects, since the smoothing property of the ICAR
prior provides the necessary shrinkage to ensure reliable county-specic estimates.
Overall, 36.5% of individuals in the study exhibited poor glycemic control (40.8%
for NHBs, 33.2% for NHWs).

Table 3.4 displays the variables that were included

in the propensity score and outcome models. These variables include demographic
information and comorbidities that have been shown to be associated with poor
glycemic control [38].
In order to visualize geographic dierences in racial distribution and poor glycemic
control, we aggregated the data to the county level and constructed unadjusted maps
of raw percents of NHBs and poor glycemic control by county (Figure 3.1, rst col-
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umn).

Additionally, we assembled maps of local indicators of spatial association

(LISA) to identify clusters and outliers of high and low percent NHBs and uncontrolled HbA1c (Figure 3.1, second column). Using local Moran's I tests with an

α

level of 0.10, we classied counties into four types: high-high clusters, dened as
counties with signicantly high rates of NHBs (top row) or uncontrolled HbA1c (bottom row) surrounded by other counties with signicantly elevated rates of these variables; high-low outliers, dened as counties with signicantly high rates of NHBs
or uncontrolled HbA1c surrounded by neighboring counties with signicantly low
rates; and low-high outliers and low-low clusters, which were dened analogously.
All other counties exhibited non-signicant spatial eects. The results indicate distinct geographical patterns in racial distribution and poor glycemic control. There
are several clusters with high percentages of NHB veterans, primarily in South Carolina, western Georgia, and central Alabama (Figure 3.1, top row). Many of these
same areas also exhibited above-average uncontrolled HbA1c (Figure 3.1, bottom
row), particularly western portions of Georgia and Alabama. In contrast, counties
in northern Georgia exhibited below-average percents of NHB veterans and uncontrolled HbA1c.

These patterns point to potential associations between residential

location, race, and poor glycemic control, suggesting that geographic confounding
may be present in this study.

Spearman's correlation between percent NHBs and

percent uncontrolled HbA1c across the counties was 0.224 (p-value = 0.0002), further supporting this conclusion.
Next, we compared the covariate balance between NHB and NHW veterans
in unweighted, non-spatial propensity score weighted, and spatial propensity score
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Figure 3.1: Unadjusted percents and local indicators of spatial association (LISA)
for NHB and poor glycemic control. Top left: Unadjusted percent NHB; Top Right:
NHB LISA; Bottom Left: Unadjusted percent poor glycemic control; Bottom Right:
Poor glycemic control LISA.

weighted samples. To construct the non-spatially weighted sample, we t a logistic
propensity score model that included only the xed patient-level covariates described
in Table 3.4. To construct the spatially weighted sample, we t a logistic propensity
score model that included these same covariates as well a spatial intercept. We then
used the subject-specic weights to form weighted means and proportions across the
covariates [60]. Standardized dierences were used to compare the covariate distributions across the two race groups [2].

We also derived county-specic weighted

proportions of NHB and NHW veterans and mapped the distribution of the un-
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weighted, non-spatially weighted and spatially weighted proportions. If the spatial
propensity score model is adequately specied, the weighted covariate distributions
and spatial patterns should be similar across race groups.
The results are presented in Table 3.4 and Figure 3.2. As Table 3.4 indicates, the
weighted samples showed vastly improved balance compared to the unweighted sample, suggesting a well-specied propensity score model at the patient level. Figure
3.2 shows the spatial distribution of NHB and NHW veterans under the unweighted,
non-spatially weighted and spatially weighted samples. In both the unweighted and
non-spatially weighted samples, the spatial distribution of NHB and NHW veterans
varied substantially. For example, a larger proportion of NHB veterans lived in central Georgia and central and western Alabama, whereas a larger proportion of NHW
veterans lived in northern Alabama and Georgia. This spatial imbalance is not surprising since the spatially unweighted samples fail to account for dierences in the
spatial distribution of the two race groups. After spatial weighting, the spatial distribution of NHB veterans more closely resembled that of NHW veterans (unweighted
Spearman correlation between race groups = 0.602, non-spatially weighted Spearman
correlation = 0.629, and spatially weighted Spearman correlation = 0.996). These
results highlight the need to balance on both individual- and county-level factors
when groups dier with respect to both sets of characteristics.
Next, we derived three estimates of the global average controlled risk dierence
between NHBs and NHWs: an unadjusted estimate, and non-spatial DR estimate,
and spatial DR estimate. To construct the non-spatial estimate, we t propensity
score and outcome models that included only the xed covariates described in Table
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Table 3.4: Balance of covariates between NHB and NHW veterans in unweighted,
non-spatially weighted, and spatially weighted samples; Stand. Di.

denotes the

absolute value of the standardized dierence.

Variable

Unweighted

Age
Male
Service Percent ≥ 50
Married
Urban
Substance Abuse
Anemia
Cancer
Cerebrovascular Disease
Congestive Heart Failure
Cardiovascular Disease
Depression
Hypertension
Liver Disease
Lung Conditions
Electrolyte Diseases
Obesity
Psychoses
Peripheral Vascular Disease
Other Disease

Non-spatially Weighted

Spatially Weighted

NHB

NHW

Stand. Di.

NHB

NHW

Stand. Di.

NHB

NHW

Stand. Di.

64.21

69.96

0.596

68.20

67.51

0.066

68.04

67.40

0.062

93.21

97.59

0.210

96.11

95.37

0.037

96.03

95.08

0.046

46.74

36.31

0.213

41.18

40.96

0.004

40.36

40.98

0.013

54.86

68.49

0.283

58.00

65.93

0.164

58.02

64.69

0.137

70.31

52.15

0.379

58.57

59.47

0.018

59.95

59.50

0.009

10.52

4.43

0.233

6.83

6.80

0.001

6.85

6.84

0.000

3.60

3.16

0.024

3.75

3.30

0.024

3.63

3.29

0.019

2.79

2.92

0.008

3.17

2.78

0.023

2.98

2.72

0.016

4.16

3.83

0.017

4.20

3.92

0.014

4.15

3.92

0.012

8.50

9.34

0.029

9.41

8.94

0.016

9.30

8.83

0.016

9.14

16.26

0.215

13.89

13.23

0.019

13.82

13.26

0.016

34.68

26.24

0.184

31.11

31.04

0.002

30.76

31.14

0.008

87.12

82.24

0.136

84.36

83.66

0.019

83.73

83.45

0.008

3.95

2.92

0.057

3.44

3.26

0.010

3.47

3.19

0.016

12.62

18.21

0.155

16.62

15.82

0.022

16.50

15.83

0.018

6.15

4.47

0.075

5.46

5.19

0.012

5.18

5.18

0.000

23.73

20.33

0.082

21.66

21.55

0.003

21.59

21.46

0.003

7.54

3.41

0.182

5.21

5.15

0.003

5.20

5.15

0.002

6.78

8.80

0.075

8.62

7.90

0.026

8.68

7.77

0.033

21.39

16.28

0.131

18.75

18.25

0.013

18.19

18.23

0.001

3.4. Given our dual aims of estimating the ACD and conducting subsequent spatial
analysis of uncontrolled HbA1c, we adopted a Bayesian approach for inference. All
models were t in

INLA,

rst using the default priors discussed in Section 2.3. As

a sensitivity check, we ret the models using alternative priors, such as the proper
CAR, the Besag, York and Mollie (BYM) prior [32], and ICAR priors with Ga(1, 1)
and Ga(1, 0.5) precisions. In each case, we obtained results nearly identical to our
default ICAR prior. Additionally, we computed bootstrap standard errors for both
the non-spatial and spatial DR estimators by resampling with replacement from the
original dataset to create 100 new datasets of size 64 022. These samples provided an
estimate of the sampling distribution of the DR estimators. The bootstrap standard
errors were then formed by computing the standard deviation for each estimator
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Figure 3.2:

Balance of spatial distribution between NHB and NHW veterans in

unweighted (top row), non-spatially weighted (middle row) and spatially weighted
(bottom row) samples
.

across the samples. For both the non-spatial and spatial DR estimators, we found
that the bootstrap standard errors were nearly identical to those for the large-sample
approximation given in equation (3.9). We therefore report the large-sample standard
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Table 3.5:

Estimated risk dierences and 95% credible intervals (CrI) in percent

uncontrolled HbA1c under various models.

Model

Risk Dierence

95% CrI

% Reduction

Unadjusted

0.076

(0.068, 0.083)

n/a

Non-spatial DR

0.020

(0.011, 0.029)

74

Spatial DR

0.016

(0.005, 0.027)

20

errors in Table 3.5.
Table 3.5 presents the three estimates of the average risk dierence between
NHBs and NHWs. In our sample,
control compared to

40.8%

of NHB veterans experienced poor HbA1c

33.2% for NHWs, for an observed sample risk dierence of 0.076.

When individual-level factors in Table 3.4 were included, the resulting marginal
risk dierence decreased from

74%

decrease.

to

0.020

(95% interval:

[0.011, 0.029]), for a

After including a spatial random eect in both stages of the PSA,

we observed a further

ˆ DR = 0.016
∆

0.076

20%

decrease in the risk dierence for a nal estimate of

(95% interval:

[0.005, 0.027]).

Thus, failing to incorporate spatial

variation would have overestimated the true risk dierence in HbA1c control. These
results are consistent with previous studies that have found modest reductions in
race disparities after accounting for geographic factors [61].
Once a global estimate of the risk dierence was established, the second goal of
our analysis was to examine spatial variation in the risk of uncontrolled A1c after
accounting for potential confounders including race. This secondary aim shifts our
focus from estimating a global disparity to identifying hotspots of elevated risk of
poor glycemic control after controlling for important patient-level covariates. While
we strongly recommend using the spatial DR estimator to address geographic con-
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Figure 3.3: Spatial random eects by county and corresponding signicance assessed
via 95% credible interval (e.g., High if interval entirely positive, Low if entirely
negative)

founding in estimating the overall race disparity, spatial random eect predictions
from a well-constructed outcome model alone can lend investigators valuable information in allocating resources and targeting communities. Figure 3.3 displays the
tted spatial random eects and indicates signicant spatial eects, assessed in terms
of the 95% credible intervals of the random eect estimates. If the interval was entirely positive, the county was designated as high signicant and if the interval
was entirely negative, the county was designated as low signicant.

The results

indicate a cluster of counties with high eects stretching from central Georgia to
Alabama, an area historically encompassed by the stroke belt [62].

In contrast,

many counties in South Carolina were identied as low signicant, indicating adequate glycemic control. Interestingly, some counties showed signicant eects only
after covariate adjustment, e.g., in the southwestern corner of Alabama. As these
counties are designated low signicant, they demonstrate that once patient-level
factors are accounted for, they have signicantly improved HbA1c control compared
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to surrounding areas. This suggests that the unadjusted dierences observed in Figure 3.1 can be explained in part by the demographic make-up these counties. These
ndings point to the need for community-based and locally-tailored interventions in
areas of highest need, particularly along the stroke belt.

3.5 Discussion
We have proposed a spatial DR estimator to estimate a minimally biased average
controlled risk dierence among race/ethnicity groups in health disparity studies.
The spatial DR estimator is an augmentation of the well-established DR estimator and extends recent work in multilevel DR estimation to the spatial setting. To
construct the estimator, we introduced spatial random eects into the propensity
score and outcome models to account for spatial variation due to potential unmeasured geographic confounders.

The spatial eects were assigned CAR priors that

promote local spatial smoothing to improve small-area estimation.

For statistical

inference, we considered both Bayesian and frequentist estimation methods that can
be implemented in freely available software such as R or SAS. In the case of Bayesian
estimation, we separated the propensity score and outcome models to avoid feedback
[55] between the models. We instead used the predictions from the separate models
to construct an appropriate DR estimator, which was in turn used to estimate the
global ACD.
Through a series of simulation studies, we explored the performance of the spatial DR estimator under varying degrees of spatial heterogeneity and sample size.
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When the true generating model incorporated geographic confounding, the spatial
DR estimator consistently demonstrated lower bias, lower RMSE, and more reliable
coverage than its non-spatial counterpart.

Conversely, when the true generating

model excluded geographic confounding, the spatial DR estimator performed on par
with its correctly specied non-spatial counterpart. In our sub-study, we introduced
county-level covariates that were subsequently omitted during model tting.

The

results demonstrated that the spatial DR estimator provided unbiased estimates and
retained near optimal coverage in the absence of the covariates. This suggests that by
incorporating spatial random eects into the estimation process, the spatial DR estimator can alleviate omitted-variable bias at the cluster level. Together, these results
point to the benet of spatial DR estimator in correcting for geographic confounding
in health disparities studies.
Our application explored the impact of geographic confounding in racial disparities among a sample of diabetic veterans residing in the southeastern United States.
After demonstrating improvement in balance in the propensity score weighted sample, we constructed three estimates of the racial disparity in uncontrolled HbA1c:
an unadjusted estimate, a DR-based estimate that adjusted only for individual-level
factors, and a spatial DR estimate that adjusted for county-level eects. Our results
suggest that adjustment for geographic confounding bias is essential to obtaining an
accurate estimate of the global risk dierence across large spatial regions. In particular, we found a

20%

reduction in the health disparity after adjusting for spatial

eects. This reduction is consistent with other studies that incorporate geographic
information in racial disparities work [61] and may point to dierences in access to
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care at the community level.

The secondary aim of this study identied areas of

poor glycemic control in central Alabama and Georgia and relatively good control in
coastal South Carolina after controlling for patient characteristics. As a whole, this
information can help community stakeholders direct attention, resources, and policy
eorts in a cost-eective manner to ameliorate diabetes-related disparities.
Throughout the paper, we have used the term geographic confounding to describe cluster-level spatial heterogeneity that is associated with both race designation and health outcomes. We have deliberately adopted this nomenclature to avoid
confusion with the more commonly used term spatial confounding, which in the
spatial literature is used to describe a type of collinearity that arises between Gaussian process random eects and spatially patterned cluster-level covariates,

X.

As

Hodges and Reich [63] demonstrate, spatial collinearity can lead to biased estimates
of the xed eect parameters when the spatial eects and xed covariates compete
for overlapping information. To address this issue, they propose a restricted spatial
regression that constrains the spatial eects to the orthogonal complement of

X.

We have taken a fundamentally dierent approach by separating the estimation and
modeling stages of spatial PSA. By adopting a two-stage PSA approach, we shift the
focus from
i.e.,

Ŷij1

estimation

and

Ŷij0

of regression coecients to

in equation (3.8).

prediction

of potential outcomes,

We then use the DR estimator for controlled

descriptive comparisons. Thus, the spatial random eects serve only to improve the
propensity score and outcome predictions that feed into the DR estimator, rather
than to remove bias in the race eect estimate,

α̂, in outcome model (3.11).

As such,

we are less concerned with correctly partitioning the spatial eect into xed and
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random components than with accurately predicting propensity scores and potential
outcomes using all available spatial information. This goal is supported by previous
literature suggesting that collinearity itself is not a primary concern in PSA as long
as the predicted propensity scores yield balanced group comparisons [13].
On a more practical note, many authors dene health disparity as a social construct encompassing historic, geographic and system-level injustices that engender
health dierences between race groups [64]. Viewed in this way, it may be inappropriate to control for geographic confounding when estimating health disparities, as
this would remove part of the disparity eect.

Our aim has not been to re-dene

what constitutes a disparity, but rather to obtain a fully adjusted estimate of the
risk dierence in glycemic control across race groups.

In other words, we wish to

make comparisons between racial groups that reside in similar geographic areas. By
comparing unadjusted, partially adjusted, and fully adjusted risk dierences, as we
did in Table 3.5, investigators can disentangle the factors that contribute to racial
disparities, a goal of recent disparity studies [65].
Future work might accommodate multiple exposure categories, taking advantage
of recent methods for causal inference among multiple treatment groups [66]. The
proposed method could also be adapted to handle propensity score matching or
stratication. More broadly, the approach could be embedded within a larger spatial
causal inference framework, to investigate spatially varying treatment eects, i.e.,
a space-by-race interaction, spatially varying selection bias, or spatial mediation
eects. Finally, the work presented here could be applied to other population health
settings, such as studies involving telehealth or spatially varying environmental ex-

63

posures.
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Abstract:

We introduce a spatial propensity score matching method to account

for geographic confounding, which occurs when the confounding factors, whether
observed or unobserved, vary by geographic region.

We augment the propensity

score and outcome models with spatial random eects, which are assigned conditionally autoregressive priors to improve inferences by borrowing information across
neighboring geographic regions. Through a series of simulations, we show that ignoring spatial heterogeneity results in increased absolute bias and mean squared error,
whereas incorporating spatial random eects improves inferences whether the treatment eect is estimated with or without further regression adjustment in the model
for the outcome. We apply this approach to a study exploring racial disparities in
diabetes specialty care between non-Hispanic black and non-Hispanic white veterans.
We construct multiple global estimates of the risk dierence in diabetes care: a crude
unadjusted estimate, an estimate based solely on patient-level matching, and an estimate that incorporates both patient and spatial information. The crude unadjusted
estimate suggests that specialty care is more prevalent among non-Hispanic blacks,
while patient-level matching indicates that it is less prevalent. Hierarchical spatial
matching supports the latter conclusion, with a further increase in the magnitude
of the disparity.

These results highlight the importance of accounting for spatial

heterogeneity in propensity score analysis, and suggest the need for clinical care and
management strategies that are culturally sensitive and racially inclusive.
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4.1 Introduction
Type 2 diabetes is the seventh leading cause of death in the United States (CDC,
2014) and disproportionately aects US military veterans [67]. Not only is diabetes
more prevalent among veterans [68], but veterans also experience higher comorbidity
rates and increased risk of complications than the non-veteran population [69, 70].
The Department of Veterans Aairs (VA) has recently taken steps to address access
to care through improved specialty care and emerging telehealth technologies [71].
Nevertheless, veterans continue to face a number of barriers to disease management,
including wait times, geographic isolation from care facilities, and insucient information regarding available health resources [72]. Thus, there is an ongoing need for
improved disease management eorts within the VA to help veterans manage their
diabetes through healthy diets, regular exercise, and proper medication adherence
[73].
At the same time, evidence shows that racial minorities have a higher prevalence
of diabetes [35], poorer diabetes outcomes [36], and higher mortality rates compared
to non-Hispanic whites [37].

These disparities are explained in part by individual

demographics, such as age, sex and marital status [38, 39]. However, patient demographics may explain only one piece of the puzzle. Recent work examining diabetes
care found that after accounting for both patient characteristics and facility-level
factors, the disparity between non-Hispanic white and non-Hispanic black veterans in LDL cholesterol testing actually increased, with non-Hispanic blacks having
lower rates of appropriate LDL management [74]. Studies have also shown that care
providers may experience clinical inertia, whereby a provider fails to respond to a
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patient's need for intensied treatment [75]. Indeed, a recent VA study demonstrated
widespread clinical inertia in the treatment of veterans with diabetes [76]. Just as
personal barriers to disease management may disproportionately aect racial minorities [36, 77], clinical inertia is also thought to be exacerbated for racial minorities
whose care providers may have misleading perceptions regarding racial and ethnic
minorities' attitudes toward treatment [78]. As a result, ongoing studies are needed
to accurately quantify the extent of racial disparities in diabetes care, and to identify
strategies for improved disease management.
Because racial disparity studies are inherently observational, it is necessary to
account for multiple sources of confounding, both at individual and community levels, in order to obtain minimally biased estimates of race disparities. In particular,
it is necessary to account not only for individual-level confounding, but also geographic confounding, which occurs when confounding factors, whether observed or
unobserved, vary by geographic location. Here, we use the term confounding somewhat broadly to denote a general distortion of the true relationship between race
and diabetes-related health outcomes [79]. Depending on the problem at hand, geographic location may act as a common cause of exposure and outcome  and hence as
a true confounder  or as a mediator lying on the causal pathway between exposure
and outcome.

From a statistical standpoint, the two can be handled similarly, as

long as the goal is to estimate the adjusted or direct eect of exposure on outcome.
This is frequently the case in health disparities studies, as policymakers often wish
to quantify the direct relationship between race and health outcomes. In the special case of geographic confounding, the goal is to appropriately account for spatial
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variation when estimating the extent of racial disparities.
In this paper, we seek to understand how racial minorities engage with the health
care system compared to a group of individuals who dier from these patients only
in racial identity. Propensity score analysis (PSA) oers a principled approach to addressing this problem. Specically, PSA enables estimation of the average treatment
eect among the treated (ATT), yielding a minimally confounded response to the
question What would the experience of a racial minority have been if the individual
were not in this racial group?. The ATT is of particular interest in racial disparity
studies, since interventions arising from these studies are typically designed to improve care for specic race groups rather than the population as a whole. Propensity
score matching and weighting are two common approaches to PSA, and both can
provide unbiased estimates of the ATT. However, propensity score weighting can
often result in unstable weights and large variances under extreme propensity score
estimates [13]. Matching, on the other hand, oers an intuitive approach to forming
a control group that is similar to the treatment group across all factors included in
the propensity score model. In fact, matching has been found to perform as well as
if not marginally superior to weighting in achieving covariate balance [80].
While there is some previous work on propensity score matching in the context
of multilevel data [25] and aggregate (region-level) spatial data [26, 47, 27, 48], there
does not currently exist an integrative approach that allows spatial information to
augment patient-level information through a hierarchical data structure. We therefore propose a hierarchical spatial propensity score matching framework to address
geographic confounding when the ATT is the desired target of inference. While re-
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cent work suggests benets to within-cluster matching [81], this recommendation is
not easily extended to the spatial setting. Spatial clusters such as counties may have
very small sample sizes and may not function independently of one another in terms
of policy and resources.
To address these limitations, we augment traditional propensity score analysis
with spatial random eects to account for variation due to unobserved geographic
confounders. The random eects are assigned conditionally autoregressive prior distributions that promote localized spatial smoothing by borrowing information from
surrounding geographic areas. This information sharing is critical to improving small
area estimation. It also reects our intuition that neighboring areas share resources
and should therefore behave similarly with respect to diabetes-related health outcomes. We explore the performance of this method in simulation studies under varying degrees of spatial heterogeneity and sample size. We also conduct simulations to
assess whether the outcome variable should be modeled via unadjusted or adjusted
regression, helping to shed light on the current debate on this topic. We apply our
methods to an analysis of diabetes care and education visits within the Veterans
Health Administration. Because the VA is the largest integrated health care system
in the United States, its health care decisions and policies are far-reaching; moreover,
VA patients represent a sentinel population in health care, signaling needs of the
more general public population [34]. We show that addressing geographic confounding yields improved eect estimates of racial disparities, which can in turn help guide
policy decisions by motivating clinical care teams to engage patients, monitor diabetes management, and design racially and culturally sensitive strategies to alleviate
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disparities within the VA and beyond.

4.2 Spatial Propensity Score Analysis
4.2.1 Overview of Propensity Score Matching Methods
We begin by briey reviewing the inferential properties of PSA as outlined in Rosenbaum and Rubin [8] and summarized more recently in Lunceford and Davidian [14].

Z

Let

denote a group indicator taking values 0 or 1. In theory,

assigned treatment group (e.g.,

Z = 1

Z

can represent an

if treated and 0 if control) or a manipula-

ble exposure group. As we present our work in the context of racial disparities, we
acknowledge that race is not a manipulable exposure; however, health care system
engagement and treatment of individuals of dierent racial groups is manipulable
and should be the target of intervention should a disparity exist. For further discussion regarding perceptions of immutable characteristics within the causal framework,
see Greiner and Rubin [82] and Davis et al. [83].
According to the causal framework outlined by Rubin (1974), each individual
is assumed to have two potential outcomes

(Y1 , Y0 ),

(potentially counterfactual) outcomes under

Z = 1

observed response,
and

Y = Y0

Y,

is given by

otherwise.

question at hand.
(ATE), dened as

where

and

Y = ZY1 + (1 − Z)Y0 ,

Y1

and

Z = 0,
so that

Y0

denote the

respectively.

Y = Y1

if

The

Z =1

The causal estimand of interest depends on the clinical

Common choices are the population average treatment eect

∆AT E = E(Y1 ) − E(Y0 ),

eect on the treated (ATT), dened as

or the population average treatment

∆AT T = E(Y1 − Y0 |Z = 1).
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The former

provides a causal comparison between the treated and the entire control population,
while the latter provides a causal comparison restricted to the treated population.
The ATT is often desired in program evaluation or when the treatment is not likely
to be targeted universally, as is the case in our motivating study.
Under unconfoundedness, propensity score methods can be used to derive unbiased estimators of the ATE or ATT in observational studies. The propensity score,

e(x) = Pr(Z = 1|X = x),
ates

X,

is the conditional probability of exposure given covari-

where the so-called overlap condition,

0 < e(x) < 1,

is assumed to hold.

Propensity score matching is a technique that forms matched pairs between exposed
and unexposed subjects based on the similarity of their estimated propensity scores
[8, 18, 2]. As is true across all propensity score methods, matching techniques require the analyst to rst decide on the form of the propensity score model (typically
a logistic regression model) and the variables to be included in the model.

After

propensity scores have been generated, the analyst must rst make decisions on the
matching strategy: greedy or optimal algorithms, matching with or without replacement, the matching variable itself (e.g., propensity score or the logit of propensity
score), and the rules for designating acceptable matches. Because the focus of this
work is to address geographic confounding through the use of spatial random eects,
our analysis strives to incorporate well evidenced propensity score methods that lend
themselves to otherwise straightforward inference.
Greedy algorithms create nearest-neighbor best pair matches by iteratively choosing an individual in the treatment group, nding the control with the most similar
propensity score and removing that pair from the selection process.
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Thus, greedy

matching does not revisit matches once they are formed. Recent work has shown that
greedy algorithms perform similarly to other matching procedures in their ability to
form well-balanced groups [13]. Matching with replacement allows a control unit to
be used in more than one pair match, whereas without replacement restricts a control
to participation in only one matched pair. Matching with replacement can yield a
suitable matched sample; however, a matched sample based on very few inuential
control units can lead to inated variance estimates [7]. Therefore, some researchers
recommend matching without replacement, which has been found to perform as well
as matching with replacement but avoids analytic complexity and the variance pitfall [20]. In terms of acceptable match designation, Austin [2] recommends a caliper
width equal to 0.2 times the standard deviation of the logit of the propensity score
as a valuable compromise between preserving match quality and minimizing mean
square error (MSE) of the treatment eect. Given the above recommendations, we
adopt a nearest neighbor algorithm that matches individuals without replacement
based on the logit of the propensity score and a caliper of 0.2 times the standard
deviation. These choices yield a sample of treated individuals and a well-matched
control group that is a subset of the entire control population, naturally allowing
for estimation of the ATT. Finally, some authors recommend tting an adjusted regression model to the outcome to address any residual imbalance between exposure
groups [13], while others advocate for an unadjusted model [2]. Given this ongoing
debate [84], we consider both approaches in our simulations studies to determine the
preferred method in the context of spatial PSA.
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4.2.2 Multi-level Spatial Matching
PSA has been recently extended to the hierarchical data setting in which individuals are nested within clusters such as health care plan [9].

Arpino and Mealli

[25] in particular have proposed propensity score matching methods for hierarchical
data that incorporate random eects into the propensity score model when withincluster matching is not feasible. They demonstrate that random eects are capable
of capturing unmeasured heterogeneity that occurs when cluster-level confounders
are omitted in PSA.
The multilevel matching estimator proposed by Arpino and Mealli [25] is readily
extended to the spatial setting by augmenting the propensity score model with spatial
random eects. Turning to our motivating application, let
taking the value 1 if the
care visit, let

Zij

j -th

patient residing in the

i-th

Yij

be an indicator variable

county receives a specialty

be an indicator taking the value 1 if the patient is non-Hispanic

black (NHB) and 0 if non-Hispanic white (NHW), and let

xij

represent a set of

observed patient- and county-level covariates. The spatial propensity score model is
given by
logit(eij )

where

φ1i

= logit[Pr(Zij = 1|Xij = xij , φ1i )] = xTij β + φ1i ,

is the spatial random eect for county

i.

The spatial eect

(4.1)

φ1i

accounts

for unmeasured county-level factors associated with race, and circumvents the need
to match within county, which is infeasible in the case of small cluster sizes.
Once the propensity scores are estimated, we match each NHB patient to a corresponding NHW patient to form a matched sample. The R package
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Matching

[85]

allows for direct input of the desired matching variable, is exible enough to accommodate various strategies, and has been used in multilevel matching [81]. After
matching, we can estimate the ATT by performing unadjusted regression analysis.
Alternatively, Stuart [13] recommends tting an adjusted outcome model that can
address residual imbalance across the groups with respect to important covariates
and space. To t the adjusted outcome model, we again incorporate a spatial random
eect into our binary outcome model

logit[Pr(Yij

where

φ2i

= 1|Zij = zij , Xij = xij , φ2i )] = xTij γ + zij α + φ2i ,

denotes the spatial random eect for county

i

(4.2)

in the outcome model. The

spatial random eects can represent geographic variability in health care access,
availability of community outreach and medical education programs, or access to
other resources associated with diabetes management. To investigate the impact of
adjusted regression on the outcome in spatial settings, we pursue both unadjusted
and adjusted estimates as part of our simulation study.
To encourage maximal spatial smoothing, we assign the random eects

φ2i

φ1i

independent intrinsic conditional autoregressive (ICAR) priors [32]. Let

denote the propensity score model and
prior for

φki

k =1

The ICAR

takes the conditional form

φki |

where

k = 2 denote the outcome model.

and

h ∼ i

φk(−i) , σk2

∼N

indicates that county

1 X
φkh , σk2 /mi
mi h∼i
h

!
, k = 1, 2,

is a geographic neighbor of county
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(4.3)

i , mi

is

the number of neighbors, and, for model
given the remaining spatial eects,
distribution for

φk

=

(φk1 , . . . , φkn )T

π(φk |

where
and

φk(−i) .

σk2 )

k , σk2

is the conditional variance of

Following Brook's Lemma [33], the joint

is given by


1 T
∝ exp − 2 φk Qφk , k = 1, 2,
2σk


Q = M −A is a spatial structure matrix of rank n−1, with M

A

representing an

aih = 0

n×n

φki

adjacency matrix with

(4.4)

= diag(m1 , . . . , mn )

aii = 0, aih = 1

if

i ∼ h,

and

otherwise. When a xed intercept is included in the model, a sum-to-zero

constraint must be applied to

φk

to ensure an identiable model.

The ICAR prior is appealing because it imposes spatial smoothing, reecting the
intuition that adjacent spatial units are more similar in terms of access to health
care, resources and policies than non-neighbors. Moreover, by promoting localized
spatial smoothing and information sharing from surrounding geographic areas, the
ICAR prior reduces uncertainty in estimating the propensity scores and, in turn, the
ATT.

4.2.3 Model Fitting and Inference
For our case study, we adopt a Bayesian model tting approach and assign prior
distributions to all model parameters. As a default, we assign weakly informative
N(0, 1e5) priors to xed eects and Ga(1, 5e-05) priors for the spatial precision terms,
where Ga(a, b) denotes a gamma distribution with shape parameter
rameter

b.

a

and rate pa-

We t the propensity score and outcome models separately, thus avoiding
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the so-called feedback issue that can arise when the models are t jointly under a
fully Bayesian approach [31]. We use approximate Bayesian methods for posterior inference. Specically, we adopt the ecient integrated nested Laplace approximation
(INLA) proposed by Rue et al. [56]. INLA uses a Laplace approximation to estimate the joint posterior of the model parameters, yielding improved computational
capabilities over standard Markov chain Monte Carlo routines.
be readily implemented in the R package

INLA

option is used to specify the ICAR prior.

This method can

(www.r-inla.org), where the

Besag

The posterior means of the propensity

scores are then used to match individuals.
In our application, we match individuals without replacement using the logit of
the estimated propensity score with a caliper of 0.2 times the standard deviation
as recommended by Austin [2]. We consider both unadjusted and adjusted outcome
models when estimating the ATT. For both the unadjusted and the adjusted outcome
models, we compute a standardized risk dierence rst by assuming each patient
is NHB and, second, by assuming each patient is NHW. The dierence provides
an estimate of the ATT. In order to construct a credible interval (CrI) around this
estimate, we used the

inla.posterior.sample

function within R-INLA to obtain

1000 Monte Carlo draws from the approximate posterior distribution. The mean of
the risk dierence across the 1000 samples is reported as the estimated ATT, and
the corresponding the 95% CrI is derived from the 2.5 and 97.5 percentiles.
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4.3 Simulation Study
4.3.1 Data Description
In order to assess the properties of hierarchical spatial matching, we conducted two
simulation studies. The goal of the rst study was to quantify the impact of ignoring
true spatial heterogeneity when estimating propensity scores, to measure the performance of the proposed spatial PSA methodology under various reasonable true-data
scenarios, and to suggest options within readily available software to achieve a minimally biased estimate of the ATT. The goal of the second study was to assess how
well the proposed method accounts for omitted variable bias.
To mirror the spatial structure of our application, for both studies we generated
patient-level data clustered at the county level across the southeastern United States.
To emulate the geographic structure in our application, we used the US Census
county-level adjacency matrix for South Carolina, Georgia, and Alabama [42]. This
matrix contains

n = 272

counties and

1528

pairwise adjacencies. For the rst study,

we generated 100 datasets with treatment assignment and outcome according to the
following propensity score and outcome models:

logit[Pr(Zij
logit[Pr(Yij

where

= 1|Xij = xij , φ1i )] = β0 + xTij β + φ1i

= 1|Zij = zij , Xij = xij , φ2i )] = γ0 + xTij γ + zij α + φ2i ,

i = 1, . . . , 272, j = 1, . . . , ni

and

xij

is a

5×1

(4.5)
(4.6)

vector comprising patient-level

covariates generated from the following distributions: N(5,2), N(0,1), Bernoulli(0.4),

78

Bernoulli(0.2), Bernoulli(0.05).

The xed eect coecients were set at

and

β = {−0.15, −0.2, 0.5, 0.6, −0.3}, γ0

= 0.25,

and

α = 0.60; ni

= 25, 50)

was allowed to vary (ni

to those in the application;
equation (4.4) with
The case where

φ1i

and

σ 2 = {0, 3, 6}

φ2i

β0

= 0.25

γ = {−0.75, 0.1, .5, .15, −0.40},
to reect sample sizes similar

were simulated from ICAR models given in

representing varying degrees of spatial variation.

σ 2 = 0 corresponded to the scenario in which geographic confounding

was not present.
For the second simulation, we evaluated the performance of spatial PSA when
relevant county-level predictors were omitted from the analysis. We augmented the
models in equations (4.5) and (4.6) with two county-level covariates, the rst generated from a N(10,3) distribution and the second simulated according to the ICAR
model given in equation (4.4) with
covariates were set to

−0.3

−0.10

and

σ 2 = 2.

0.1

The regression coecients for the two

for the propensity score model and to

for the outcome model. The spatial variances for

φ1i

and

φ2i

0.3

and

were set to 3 to

mimic the estimates in our application. We then t the propensity score and outcome models ignoring these covariates in order to assess the impact of the omitted
variables on the ATT estimate.

4.3.2 Results
Table 4.1 summarizes the results of the rst simulation study. This table presents
measures of performance of spatial propensity score matching under varying degrees
of spatial variation and sample sizes. Rows indicate the sample size and spatial variance values; columns indicate whether the estimate was derived from an unadjusted
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Table 4.1: Results for simulation study 1: Mean bias, RMSE, and 95% coverage
of the risk dierence under various sample sizes and spatial variances (rows) and
2
estimation methods (columns). σφ = 0 represents no spatial variation
Unadjusted
Non-spatial

σφ2 = 0
ni = 25
ni = 50
σφ2 = 3
ni = 25
ni = 50
σφ2 = 6
ni = 25
ni = 50

Adjusted
Spatial

Non-spatial

Spatial

0.007

0.008

96

0.007

0.009

88

0.007

0.008

94

0.007

0.009

90

0.005

0.007

88

0.006

0.008

87

0.006

0.007

87

0.007

0.008

85

0.014

0.018

65

0.011

0.013

89

0.014

0.018

62

0.009

0.011

90

0.013

0.017

53

0.008

0.009

87

0.014

0.018

49

0.006

0.007

92

0.021

0.027

51

0.011

0.014

92

0.022

0.028

46

0.009

0.011

92

0.021

0.029

42

0.010

0.013

77

0.021

0.029

37

0.006

0.008
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model that included an indicator for race only or an adjusted model that included
patient covariates with and without an additional spatial random eect. Within each
strategy, columns further indicate whether spatial random eects were incorporated
in the analysis.

Explicitly, Unadjusted, Non-Spatial implies that the propensity

score model included only individual-level covariates, while the outcome model included only a indicator for race; Unadjusted, Spatial implies that the propensity
score model included both individual-level covariates and a spatial random eect,
while the outcome model included only race; Adjusted, Non-spatial implies that
the propensity score and outcome models ignored space but included individual-level
covariates; and Adjusted, Spatial implies that with t a fully adjusted spatial model
for both the propensity score and outcome models.
Several trends are apparent in Table 4.1. First, ignoring geographic confounding
and utilizing only patient-level measures is detrimental.
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We observe poor perfor-

mance of the non-spatial analyses as the bias and RMSE are increased while the coverage is decreased. Secondly, regression adjustment appears to yield smaller bias and
RMSE than unadjusted analysis and typically better coverage when spatial analyses
are performed. For example, when

σφ2 = 3

and

ni = 50

and space is ignored, cover-

age is 53% and 49% in the unadjusted and adjusted analyses, respectively. However,
when spatial PSA is conducted for the same data, we observe near-nominal coverage,
with the additional adjustment in the outcome model yielding a slightly better result
than the unadjusted outcome analysis (92% versus 90%). Lastly, in the case of no
true spatial heterogeneity, conducting spatial analysis does not appear to be highly
detrimental, as it contributes no additional bias.

ni = 50,

For instance, when

σφ2 = 0

and

non-spatial and spatial analyses yielded nearly identical coverage probabili-

ties. We observe similar trends in measures of bias and RMSE. These results suggest
that incorporating spatial random eects into the propensity score model and the
adjusted outcome model yields favorable results when spatial variation is present and
does not yield negative consequences when the data exhibit no spatial heterogeneity.
Table 4.2 presents results of the second study using INLA to estimate the propensity score and outcome models. The goal of the second study was to assess the ability
of the proposed spatial matching framework to capture the true ATT when relevant
county-level covariates were left out of the analysis. The non-spatial analyses ignored
space entirely and t either an unadjusted model for the outcome or a non-spatial,
covariate adjusted outcome model. The spatial analyses incorporated a spatial random eect in the propensity score model and t either an unadjusted model for the
outcome or a spatial and patient-level adjusted model for the outcome.
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As Table

Table 4.2: Results for simulation study 2: Mean bias, RMSE, and 95% coverage of the
risk dierence under various sample sizes (rows) and estimation methods (columns)
2
with a xed spatial variation (σφ = 3)
Unadjusted
Non-spatial

ni = 25
ni = 50

Adjusted
Spatial

Non-spatial

Spatial

0.018

0.027

76

0.012

0.016

94

0.018

0.027

71

0.010

0.013

94

0.019

0.025

77

0.009

0.011

94

0.015

0.021

67

0.008

0.010

94

4.2 indicates, the non-spatial analysis performed poorly, whereas the spatial analyses retained favorable properties across all scenarios, including low bias, low RMSE
and near-nominal coverage. These results support the use of the proposed spatial
matching framework, as it appears to capture the true risk dierence even when
county-level xed eects are ignored during model tting. As it is not uncommon
for these covariates to be unavailable to the analyst, spatial matching provides a
practical strategy to account for unmeasured geographic confounding. Together, the
results of the simulation studies demonstrate that spatial propensity score matching
through the inclusion of spatial random eects addresses geographic confounding and
outperforms analyses that include only patient-level covariates.

4.4 Analysis of Racial Disparities in Diabetes Care
and Management
We conducted an analysis to examine the direct association between race and the
likelihood of a diabetes care visit in 2014.
(n

= 9, 277)

and NHW (n

= 11, 359)

Our sample consisted of 20,636 NHB

veterans with uncontrolled type 2 diabetes
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living in Georgia, Alabama and South Carolina. Uncontrolled type 2 diabetes was
dened as HbA1c

≥ 8

at the start of 2014.

Table 4.3 displays the patient-level

variables that were included in the propensity score and adjusted outcome models.
Approximately 13% of the patients had a diabetes care visit following indication of
poor control (15.0% for NHBs, 11.2% for NHWs).

Figure 4.1: Unadjusted percent of veterans with uncontrolled diabetes who are NHB
(left) and unadjusted percent of veterans with uncontrolled diabetes who received a
diabetes care education visit (right)

Figure 4.1 displays the per-county percents of NHB veterans and veterans with
diabetes care visits. The maps suggest that the percent of NHB veterans and the
percent of veterans with diabetes care visits exhibit spatial variation, with clustering
around areas in western Alabama, Atlanta, Georgia and coastal South Carolina.
In order to assess the covariate balance between NHB and NHW veterans in the
original and spatial propensity score matched samples, we estimated the dierence
in means or proportions in each of the samples. To construct the spatially matched
sample, we t a logistic propensity score model that included the patient-level co-
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Table 4.3: Balance of covariates between NHB and NHW veterans in pre-matched
and post-matched samples; Stand. Di.

denotes the absolute value of the stan-

dardized dierence

Variable
Age
Female
Service Percent ≥ 50
Married
Substance Abuse
Cerebrovascular Disease
Congestive Heart Failure
Cardiovascular Disease
Depression
Hypertension
Obesity
Psychoses
Homeless

Pre-match

Post-match

NHB

NHW

Stand. Di.

NHB

NHW

Stand. Di.

62.00

67.49

0.573

64.52

64.49

0.003

7.43

2.67

0.219

7.38

6.83

0.021

45.97

39.41

0.133

45.95

48.20

0.045

52.83

65.79

0.266

52.88

57.84

0.099

11.04

4.46

0.248

10.99

10.51

0.015

3.58

3.24

0.019

3.57

3.69

0.006

8.58

11.07

0.084

8.58

8.69

0.004

8.46

15.64

0.222

8.47

8.89

0.015

35.94

31.55

0.093

35.92

36.11

0.004

88.41

84.44

0.116

88.42

86.65

0.054

27.23

25.87

0.031

27.23

27.71

0.011

6.83

3.81

0.135

6.82

7.09

0.011

0.91

0.18

0.099

0.86

0.99

0.014

variates described in Table 4.3 and a spatial intercept term.

Matching was based

on the logit of the estimated propensity score and a caliper of 0.2 times the standard deviation of the logit is imposed in order to ensure a well-matched sample. We
observed a decrease in the standardized dierence across the patient-level covariates in the spatially matched sample. However, some standardized dierences were
still sizable; for example, the standardized dierence for married is close to 0.10,
which would be considered the threshold for negligible dierence. We were therefore
motivated to consider regression adjustment in the outcome model to address any
residual imbalance.
Figure 4.2 displays the spatial distribution of NHB and NHW veterans in the
unmatched and spatially matched samples.
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The spatial distribution of NHB and

Figure 4.2:

Balance of spatial distribution between NHB and NHW veterans in

unmatched (top row), and spatially matched (bottom row) samples
.

NHW veterans varied in the unmatched sample, implying that NHBs and NHWs were
concentrated in dierent areas. While a high percent of both NHB and NHW veterans
live in urban areas such as Atlanta, NHW veterans alone appear to be concentrated in
northern Georgia, where only 0.00% to 0.043% of NHB veterans reside (lightest shade
on the map). This spatial imbalance is ameliorated once a spatially matched sample
is created. In the spatially matched sample, the distribution of NHW veterans (the
controls) more closely mimics the nearly unchanged distribution of NHB veterans
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(the treated), indicating that we have selected geographically well-matched controls.
To assess the performance of the proposed spatial PSA, we t ve models. We
rst examined the observed sample risk dierence in diabetes care between NHB and
NHW (unadjusted analysis). Next, we performed a non-spatial analysis that included patient covariates in the propensity score model, but not in the outcome model
(Patient I analysis). Third, we replicated the patient covariates in the propensity
score model and additionally t a covariate adjusted logistic regression model for the
outcome (Patient II analysis). Fourth, we t a model that included an additional
spatial random eect in the propensity score model, while the outcome model was
left unadjusted (Spatial I analysis). Finally, we conducted a fully adjusted spatial
PSA that included patient-level covariates and spatial random eects in both models
(Spatial II analysis). We used the estimated coecients from the model to form a
standardized estimate of the risk dierence. The reported 95% CrI was constructed
using the 2.5 and 97.5 percentiles of the sample distribution of risk dierences.
Results of this stepwise analysis are presented in Table 4.4. The unadjusted risk
dierence indicates that NHB veterans with uncontrolled diabetes have a greater
probability of receiving diabetes care and education (risk dierence = 0.038, 95%
CrI = [0.029, 0.047]).

This result is somewhat counterintuitive in light of recent

studies on care management, which have found that NHBs are less likely to receive
intensied treatment [78].

However, NHB veterans included in this analysis were

more likely to be obese, female, and have a higher rate of service connected disability
(Table 4.3). The imbalance in these factors may explain the positive direction of the
disparity. Once we matched on patient level factors (Patient I), the risk dierence
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reversed direction (-0.021, 95% CrI = [-0.031, -0.011]), indicating that NHB veterans
with uncontrolled diabetes have a lower probability of receiving specialized care and
education. With further covariate adjustment in the outcome model (Patient II),
the risk dierence decreased slightly (-0.027, 95% CrI = [-0.038, -0.016]) but was
similar to the estimate from the matched sample unadjusted model.

Because the

percent of NHB veterans and the percent of veterans receiving care visits by county
appear to exhibit spatial variation, it is likely that when geography is ignored, the
true disparity is not fully revealed, as NHBs may be more likely to live in areas with
high rates of care visits. When spatial random intercepts were included in the analysis
and the matched sample was geographically balanced, we observed an increase in
the magnitude of the disparity. In the unadjusted spatial analysis (Spatial I), the
estimated risk dierence was -0.057 (95% CrI = [-0.068, -0.046]).

In the adjusted

spatial analysis (Spatial II), the estimated risk dierence was -0.071 (95% CrI =
[-0.085, -0.057]), suggesting a 7 percentage point dierence in the receipt of diabetes
care between NHBs and NHWs. While in general agreement with the eect estimate
from the unadjusted spatial analysis in the matched sample, the eect estimate from
further regression adjustment indicates a more marked racial disparity, providing
strong evidence for the incorporation of spatial random eects in both the propensity
score and outcome models.
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Table 4.4: Estimated risk dierences in the racial disparity of diabetic care visits under modeling strategies. Negative values indicate that NHBs have a lower estimated
risk of receiving a diabetic care visit. Unadjusted: observed sample risk dierence.
Patient I: covariate-adjusted propensity model, unadjusted outcome model.

Pa-

tient II: covariate-adjusted propensity score and outcome models. Spatial I: spatial
propensity score model, unadjusted outcome model.

Spatial II: spatial propensity

score and outcome models.

Model

Risk Dierence

95% CrI

Unadjusted

0.038

(0.029, 0.047)

Patient I

-0.021

(-0.031, -0.011)

Patient II

-0.027

(-0.038, -0.016)

Spatial I

-0.057

(-0.068, -0.046)

Spatial II

-0.071

(-0.085, -0.057)

4.5 Discussion
We have proposed a spatial propensity score matching framework to estimate the
ATT among racial groups in studies examining disparities in health management
and system engagement.

To account for unmeasured geographic confounding, we

incorporated spatial random eects into the propensity score model and, in the case
of further regression adjustment, into the outcome model as well. These spatial effects can represent geographic confounders such as proximity to health care facility,
access to resources, and community support and education. The spatial eects were
assigned CAR priors that promote local spatial smoothing and are able to improve estimation in areas with sparse data. We adopted a Bayesian inferential approach, but
t the propensity score and outcome models separately to avoid potential feedback
concerns that arise from joint estimation [31]. By implementing Bayesian estimation
within R-INLA, we used readily available, free software that can be utilized in a
multitude of studies across many health care data platforms.
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In simulation, we examined the performance of the proposed spatial propensity
score matching framework under varying degrees of spatial variation and sample
size. Under true geographic confounding, spatial matching outperformed matching
that failed to incorporate spatial information.

Spatial matching demonstrated de-

creased bias and RMSE and improved coverage compared to non-spatial matching.
This result was true whether the ATT was estimated by unadjusted regression in
the matched sample or further covariate and spatial adjustment was employed. In
general, regression adjustment to address residual imbalance led to lower bias and
RMSE. When true geographic confounders were ignored in the analysis, and only
a spatial random intercept was included in the modeling, spatial matching oered
reasonably low bias and RMSE and nearly nominal coverage, suggesting that the
proposed method can alleviate bias due to omitted spatially varying confounders. In
contrast, the non-spatial analysis performed very poorly. This supports the need to
address geographic confounding in studies of racial disparities.
Our application explored the impact of geographic confounding in racial disparities among veterans with uncontrolled diabetes in the southeastern United States.
We reported an unadjusted estimate of the ATT, a patient-level matched estimate, a
spatially matched estimate, and a spatially matched estimate that further addressed
imbalance through an adjusted regression model.

The crude unadjusted estimate

suggested that NHB veterans with uncontrolled diabetes may have a higher risk of
receiving a specialty care visit; however, once patient-level factors were balanced, we
saw this association reverse. Furthermore, once we additionally balanced on space,
the disparity in diabetes care visits became more pronounced, with NHB veterans
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having a lower probability of receiving a specialty care visit to address their uncontrolled diabetes.
These ndings have important policy implications for mitigating disparities in
diabetes management and for improving patient engagement with the health care
system. First, policymakers can target intervention to identify, engage and maintain
patients who are in need of intensied treatment. Vulnerable populations who are
less likely to seek specialized care may need to be recruited in local, well-trusted
community settings [86, 87, 88].

These patients may also benet from care navi-

gators or patient advocates in a complex care setting [89].

Clinician training can

also be tailored to address issues such as clinical inertia and the conduct of culturally sensitive consultations [90]. Lastly, disease management media and instruction
pamphlets can encourage patients to seek guidance and agency of their clinical care.
These policy eorts can help the VA achieve its stated mission to champion advancement of health equity and reduction of health disparities for disadvantaged Veterans
as outlined in its recent Health Equity Action Plan [91].
Future work could adapt spatial propensity score methodology to stratication
or a combination of propensity score methods.

Furthermore, the proposed meth-

ods could be extended to accommodate time-varying treatments or broader types of
outcomes, such as count, survival or multivariate outcomes. Lastly, the work presented here could be applied to numerous other public health applications, such as
studies addressing the implementation of telemedicine or spatially varying outreach
programs.
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5.1 Introduction
It is estimated that between 12 and 14 percent of Americans have type 2 diabetes,
with a heavier burden among non-white racial minorities [92].

Patients with type

2 diabetes experience more common and lengthier inpatient hospital stays and are
more likely to die in the hospital than their non-diabetic counterparts [93]. In fact,
inpatient stays are the highest medical expenditure among type 2 diabetics, accounting for 43% of the 256 billion dollars spent annually [94]. Promisingly, the number
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of days Americans spend in the hospital has been decreasing over time. However,
for ethnic and racial minorities, this trend may actually represent short but frequent
health care system encounters of poor-quality, insucient care [95].

It is still un-

clear how observed decreases in inpatient days dierentially aect racial minorities
even after disease management initiatives to reduce inpatient encounters have been
enacted [96].
There are a number of factors that may contribute to disparities in inpatient hospital stays. Barriers to access of inpatient services may vary at both individual and
facility levels. Dierences in comorbidity burden or nancial obligation in payment
for services may account for some of the racial dierences that have been reported
[97]. Patient-provider relationships and patient advocacy can also inuence hospitalizations and the number of days patients spend in the hospital [96]. Furthermore, the
use of inpatient services has been shown to vary geographically. For example, recent
studies have shown that after socioeconomic status and disease burden is controlled
for, areas with higher hospital capacity tend to have higher hospitalization rates [98].
Even in a relatively homogeneous patient population such as veterans receiving care
within the Veterans Health Administration (VHA), geographic variation in inpatient
utilization persists [99].
In this paper, we are interested in understanding racial dierences in the risk of
hospitalization and the number of inpatient days among veterans with type 2 diabetes
after accounting for potential confounding factors. Propensity score matching oers
a principled approach to addressing the issue of confounding and enables estimation
of the average treatment eect among the treated (ATT), yielding a minimally con-
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founded response to the question What would the experience of a racial minority
have been if the individual were not in this racial group?. The ATT is often of interest in health disparities studies as interventions typically target the at-risk group
rather than the population as a whole. Because community factors such as accessibility to health care facilities and availability of disease management resources can
exacerbate health disparities, it is critical to account for not only patient-level confounding but also geographic confounding, which occurs when confounding factors
vary spatially. In previous work, we have shown that incorporating spatial random
eects into the propensity score model can yield a matched sample balanced on the
distribution of racial groups across geographical regions. This in turn minimizes the
bias in estimating the ATT among the matched sample [100].
Once a matched sample is generated, tting a model for the outcome can address
any residual imbalance and may yield improved eect estimates [100, 13]. The specication of the outcome model is exible and allows analysts to tailor it to the specic
research question at hand. Two-part hurdle models [101] have been utilized in studies
examining racial disparities in inpatient stays [96], as they allow researchers to address questions regarding both the risk of hospitalization and the number of inpatient
days while accounting for zero-ination in the count response.

Hurdle models are

two-part mixture models comprising a binary component that models (in our case)
the probability of hospitalization, and a truncated count component that models the
number of days in the hospital among those who are hospitalized.

The truncated

negative binomial distribution is an attractive choice for the count model as it allows
for overdispersion relative to the Poisson assumption that the variance is equal to
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the mean. The negative binomial hurdle model can easily be extended to the spatial
setting by incorporating spatial eects into both the binary and count components
of the model.

The resulting model can be t within a Bayesian framework using

standard software such as R-INLA [56].
In this work, we combine methods in spatial propensity score matching and hierarchical spatial hurdle models to achieve minimally biased estimates of the racial
disparity in the risk of hospitalization and the mean number of inpatient days. We
conduct a simulation study to assess the performance of spatial propensity score
analysis in combination with the spatial hurdle model under unknown geographic
confounders. We apply these methods to an analysis of the eect of race on hospitalization and inpatient days among type 2 diabetic veterans receiving care within
the VHA in the southeastern United States in the 2014 scal year.

As the VHA

is concerned with reducing hospitalizations and inpatient days while simultaneously
maintaining quality care, it is important to understand dierences in health care services between non-Hispanic whites and racial minorities. Furthermore, as patients
receiving care within the VHA are often considered a sentinel population, the results of this study may indicate areas in need of attention in the general population
[34].
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5.2 Methods
5.2.1 Spatial Propensity Score Analysis
We begin by rst addressing the inferential properties and model specication of the
propensity score and extensions that incorporate a spatial random eect to address
geographic confounding. Let Z denote a race group indicator taking the value 1 if
a patient is non-Hispanic black (NHB) and 0 if non-Hispanic white (NHW). While
race itself is not a manipulable characteristic, the experience of dierent racial groups
within the health care system

is manipulable and should be the target of intervention

if an analysis demonstrates a disparity.
In the context of the causal framework outlined by Rubin [6], each individual is
assumed to have two potential outcomes

(Y (1) , Y (0) ), where Y (1)

(potentially counterfactual) outcomes under
observed response,
and

Y = Y (0)

Z = 1

and

and

Z = 0,

denote the

respectively.

Y , is given by Y = ZY (1) + (1 − Z)Y (0) , so that Y = Y (1)

if

The

Z=1

otherwise. The population ATT is the average dierence between the

potential outcomes among treated patients, formally dened as

Y (0) |Z = 1).

Y (0)

∆AT T = E(Y (1) −

The ATT is often desired in program evaluation or when the treatment

is not likely to be targeted universally, as is the case in our motivating study.
Under unconfoundedness, propensity score methods can be used to derive unbiased estimators of the ATT in observational studies. The propensity score,

Pr(Z = 1|X = x),

e(x) =

is the conditional probability of exposure given covariates

where the so-called overlap condition,

0 < e(x) < 1, is assumed to hold.

X,

Propensity

score matching is a technique that forms matched pairs between exposed and unex-
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posed subjects based on the similarity of their estimated propensity scores [2, 8, 18].
Recent work has explored the use of propensity score analysis in the hierarchical
setting, where patients are nested within clusters such as health care plans or hospitals [25, 9, 81]. Arpino and Mealli [25] proposed propensity score matching methods
for hierarchical data that incorporate random eects into the propensity score model.
In the hierarchical spatial setting, we augment the propensity score model with spatial random eects. The spatial eects are then assigned distributions that account
for spatial correlation and promote smoothing across spatial units. More concretely,
let

Zij

denote an indicator variable taking the value 1 if the

j th

patient in the

ith

county is non-Hispanic black (NHB) and 0 if non-Hispanic white (NHW), and let

xij

represent a set of observed patient-level covariates. The spatial propensity score

model is given by

logit(eij )

where

φ1i

= logit[Pr(Zij = 1|Xij = xij , φ1i )] = xTij α + φ1i ,

is the spatial random eect for county i. The spatial eect

φ1i

(5.1)

accounts for

unmeasured county-level factors associated with race, and circumvents the need to
match within county, which may be infeasible in the case of small cluster sizes [81].
By matching on the spatial propensity scores, investigators can achieve balance
across patient factors and geographical distribution between NHB and NHW patients. Once the matched sample is constructed, a variety of outcome models specic
to the research question at hand can be employed. Adjusted outcome models can be
used to address any residual imbalance between exposure groups [13] and have been
shown in simulation to be benecial to unbiased estimation of the ATT [100].
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5.2.2 Two Part Spatial Hurdle Models
Our motivating study of inpatient hospitalization practices poses a set of unique
analytic challenges.

First, approximately 71% of the patients in the sample were

not hospitalized in 2014, resulting in substantial zero-ination. Furthermore, among
those who were hospitalized, there was a wide range of counts of inpatient days.
In order to capture both zero-ination for patients who do not experience a hospitalization and overdispersion of inpatient days among patients who do experience
a hospitalization, we propose a negative binomial hurdle outcome model. A hurdle
model [101] is a two-part mixture model consisting of a point mass at zero followed by
a zero-truncated count distribution for the positive observations. The choice of count
distribution can vary, but the negative binomial distribution is attractive because it
accounts for overdispersion in the counts.
Let

Y

represent the number of inpatient days in a scal year.

The probabil-

ity of experiencing a hospitalization (i.e., any positive number of inpatient days)
is expressed as Pr(Y
bility that

Y = y

> 0) = π

where

is given by Pr(Y

0 < π < 1.

= y) =

For

y = 1, 2, ...,

πp(y;µ,r)
, where
1−p(0;µ,r)

p(y; µ, r)

the probadenotes the

probability distribution function of a negative binomial distribution with mean
and overdispersion parameter

r,

and

p(0; µ, r)

µ

denotes the negative binomial dis-

tribution evaluated at 0. The mean count among hospitalized patients is given by

E(Y |Y > 0) = ν =

µ
, while the overall all mean among hospitalized and
1−p(0;µ,r)

non-hospitalized patients is
hurdle model is

E(Y ) =

V (Y ) = ν(ν − µ) +

πµ
. The variance of the negative binomial
1−p(0;µ,r)
πτ 2
where
1−p(0;µ,r)

of the negative binomial distribution.
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τ 2 = µ(1 + µ/r)

is the variance

Turning to our case study, let

j th

patient in the

it h

Yij

denote the number of inpatient days for the

county. In this context, the negative binomial hurdle model is

expressed as

Pr(Yij = yij | xij , zij , φi , µij , r) = (1 − πij )1(yij =0) + πij TNegBin(yij ; µij , r)1(yij >0)

Γ(yij + r)
πij
= (1 − πij )1(yij =0) +
r
r
1 − ( µij +r ) Γ(r)yij !
yij 
r 

µij
r
1(yij >0) , r > 0,(5.2)
×
µij + r
µij + r
where

πij = Pr(Yij > 0)

is the probability of hospitalization and TNegBin(yij ; µij , r)

is a truncated negative binomial distribution with parameters

πij

and

µij

µij

and

r.

We model

as

logit(πij )

= xTij β + zij γ + φ2i

ln(µij ) = xTij γ + zij θ + φ3i ,
where

zij

is a binary indicator for race and, as in Equation 5.1,

of patient-level covariates and

φ2i

and

φ3i

(5.3)

xij

represent a set

are spatial random eects.

To encourage maximal spatial smoothing, we assign the random eects
and

φ3i

k=1

φ1i , φ2i ,

independent intrinsic conditional autoregressive (ICAR) priors [32].

denote the propensity score model,

risk of hospitalization, and

k=3

k=2

Let

denote the outcome model for the

denote the outcome model for the mean number
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of inpatient days. The ICAR prior for

h ∼ i

indicates that county

h

given the remaining spatial eects,

φk

=

π(φk |

where
and

φk(−i) .

(φk1 , . . . , φkn )T
σk2 )

!
, k = 1, 2, 3,

k , σk2

aih = 0

representing an

is

φki

Following Brook's Lemma [33], the joint

is given by



1 T
∝ exp − 2 φk Qφk , k = 1, 2, 3,
2σk

n×n

i, mi

is the conditional variance of

Q = M −A is a spatial structure matrix of rank n−1, with M

A

(5.4)

is a geographic neighbor of county

the number of neighbors, and, for model

distribution for

takes the conditional form

1 X
φkh , σk2 /mi
mi h∼i

φki | φk(−i) , σk2 ∼ N

where

φki

adjacency matrix with

(5.5)

= diag(m1 , . . . , mn )

aii = 0, aih = 1

if

i ∼ h,

and

otherwise. When a xed intercept is included in the model, a sum-to-zero

constraint must be applied to

φk

to ensure an identiable model.

The ICAR prior is appealing because it imposes spatial smoothing, reecting the
intuition that adjacent spatial units are more similar in terms of access to health
care, resources and policies than non-neighbors. Moreover, by promoting localized
spatial smoothing and information sharing from surrounding geographic areas, the
ICAR prior reduces uncertainty in estimating the propensity scores and, in turn, the
ATT.
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5.2.3 Treatment Eect Estimation
Because our outcome analysis involves a two-part model, we can estimate an ATT
for each part of the model. Furthermore, it is possible to combine results from both
models in order to estimate an ATT across the entire population of hospitalized and
non-hospitalized patients. The three ATTs are more formally dened as

(1)

∆1 = E(Y1

(0)

− Y1

| Z = 1)

(5.6)

∆2 = E(Y (1) − Y (0) | Z = 1, Y > 0)

(5.7)

∆3 = E(Y (1) − Y (0) | Z = 1).

(5.8)

where

Y1 =




1,

if



0,

otherwise

Y >0

is a binary indicator of hospital admission (i.e., at least one inpatient day). Equation
(5.6) yields the ATT of the racial disparity in the risk of hospitalization. Equation
(5.7) yields the ATT of racial dierences in the mean number of inpatient days among
those who were hospitalized. Lastly, equation (5.8) yields the ATT of the disparity in
the mean number of inpatient days among the entire susceptible population (those
who had a hospitalization and those who did not).

Each of the ATTs can be of

practical interest depending on the clinical or public health question at hand.
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5.3 Model Fitting
In this work, we adopt a Bayesian model tting approach and assign prior distributions to all model parameters. As a default, we assign weakly informative N(0, 1e5)
priors to xed eects and, to ensure robust precision estimates, specify Ga(1, 0.5)
priors for the spatial precision terms, where Ga(a, b) denotes a gamma distribution
with shape parameter

a

and rate parameter

b.

We t the propensity score and

outcome models separately, thus avoiding the so-called feedback issue that can
arise when the models are t jointly under a fully Bayesian approach [55]. We use
approximate Bayesian methods for posterior inference. Specically, we adopt the efcient integrated nested Laplace approximation (INLA) proposed by Rue et al. [56].
INLA uses a Laplace approximation to estimate the joint posterior of the model parameters, yielding improved computational capabilities over standard Markov chain
Monte Carlo routines. This method can be readily implemented in the R package

INLA

(www.r-inla.org), where the

Besag

option is used to specify the ICAR prior.

The posterior means of the propensity scores are then used to match individuals.
We match individuals without replacement using the logit of the estimated propensity score with a caliper of 0.2 times the standard deviation as recommended by
Austin [2] using the R package

Matching [85].

Once a matched sample is constructed,

we t spatial hurdle models. Because INLA does not have a built-in option for tting
hurdle models, we adapt the work of Quiroz et al. [102] by constructing an

N ×2

matrix of values indicating a hospitalization and the number of visits for each patient
where

N

is the total number of observations. We then jointly t a binomial model

to the binary portion, i.e. any inpatient days, and a zero-inated negative binomial
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model to the number of visits, where missing values are imposed for those who were
not admitted. The zero-inated negative binomial with missing values forces INLA
to t a zero-truncated negative binomial which, combined with the binomial model
for any inpatient days, yields a negative binomial hurdle model.

We construct an

estimate of each of the three ATTs using standardization, a technique that allows
us to marginalize across the population by estimating the predicted responses,
and

(1)

Yij

(0)

Yij

, under the observed and counterfactual racial group. In order to construct

a credible interval (CrI) around this estimate, we use the

inla.posterior.sample

function within R-INLA to obtain 1000 Monte Carlo draws from the approximate
posterior distribution. The mean of the three estimates across the 1000 samples is
reported as the estimated ATT, and the corresponding 95% CrI is derived from the
2.5 and 97.5 percentiles.

5.4 Simulation Study
5.4.1 Data Description
In order to assess the properties of spatial propensity score matching with spatial
hurdle outcome modeling, we conducted a simulation study. The goal of this study
was to assess how well the proposed method accounts for omitted variable bias,
namely when geographic confounders related to both the exposure and outcome of
interest are unknown or unmeasured and thus are not included in the propensity
score or outcome model.
To mirror the spatial structure of our application, we generated patient-level
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data clustered at the county level across the southeastern United States. To emulate
the geographic structure in our application, we used the US Census county-level
adjacency matrix for South Carolina, Georgia, and Alabama (U.S. Census Bureau,
2014) This matrix contains

n = 272

counties and

1, 528

pairwise adjacencies.

We

generated 100 datasets with treatment assignment and outcome according to the
following propensity score (Equation 5.9) and outcome models (Equations 5.10 and
5.11):

logit(eij )

= logit[Pr(Zij = 1|Xij = xij , Vi = vi , φ1i )] = α0 + xij α1 + vi α2 + φ1i

logit(πij )

(5.9)

= logit[Pr(Y1ij = 1|Zij = zij , Xij = xij , Vi = vi , φ2i )] = β0 + xij β1
(5.10)

+zij β2 + vi β3 + φ2i

ln(µij )

= ln[E(Y |Zij = zij , Xij = xij , Vi = vi , φ3i , Yij > 0)] = γ0 + xij γ1
(5.11)

+zij γ2 + vi γ3 + φ3i
where

i = 1, . . . , 272, j = 1, . . . , ni , xij

a Bernoulli(0.05) distribution and

Vi

is a patient-level covariate generated from

is a county-level covariate generated from a

N(10,3) distribution. The xed eect coecients were set at
-0.1,
0.1;

β0
ni

= -1.0,

β1

= 0.5,

was set to 100;

Equation (5.5) with

σ2

β2

= -0.3,

φ1i , φ2i ,

and

β3
φ3i

= 0.1,

γ0

= 1,

γ1

α0

-1.5,

α2

=

= 0.3, and

γ3

=

= 0.2,

= -0.5,

γ2

α1

were simulated from ICAR models given in

= 1 to mimic the spatial variation observed in the case study.
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5.4.2 Results
Table 5.1 presents results of the simulation study. The goal of this study was to assess the ability of the proposed spatial propensity score matching and spatial hurdle
model to capture the true ATTs compared to tting only a spatial hurdle outcome
model without matching when relevant county-level covariates were left out of the
analysis. As Table 5.1 indicates, tting only an outcome model resulted in poor performance, whereas tting the propensity score and outcome model yielded lower bias
and RMSE and reasonable coverage. For example, when estimating

∆2 ,

the mean

dierence in inpatient days among those who were hospitalized, tting a propensity
score model in addition to the outcome model resulted in 94% coverage compared to
54% coverage when only an outcome model was t. Misspecication of the model for
the mean count is especially detrimental, as both the coecients and the overdispersion parameter may be aected, potentially leading to extreme counts. The results
of this simulation study support the use of spatial propensity score matching prior
to tting the spatial hurdle model as it appears to capture the true risk dierence
even when county-level xed eects are ignored during model tting. As it is not
uncommon for these covariates to be unavailable to the analyst, spatial matching
provides a practical strategy to account for unmeasured geographic confounding.
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Table 5.1: Results of the simulation study: Mean absolute bias, RMSE, and 95%
coverage of the three ATTs (Equations (5.6) - (5.8)) when (left) only an outcome
model is t and (right) a propensity score (PS) and outcome are t under an omitted
spatial covariate scenario

ATT
∆1
∆2
∆3

Outcome Model Only PS + Outcome Model
Bias

RMSE

Coverage

Bias

RMSE

Coverage

0.007

0.010

90

0.007

0.009

91

0.311

0.396

54

0.159

0.304

94

0.118

0.165

80

0.111

0.149
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5.5 Analysis of Racial Disparities in Hospitalization
and Inpatient Days
5.5.1 Data Description
The data consist of 23,533 veterans (9, 695 NHB;

13, 838 NHW) with type 2 diabetes

living in Georgia, Alabama and South Carolina in 2014.
of 272 counties had a mean county sample size of

This geographic region

n = 86.5

(range:

1

to

1, 385).

Figure 5.1 displays the per-county percent of NHB veterans, percent of veterans
who experience a hospitalization, the mean number of inpatient days among those
with a hospitalization, and the mean number of inpatient days across all patients.
These maps suggest spatial variation in racial clustering and hospitalization patterns.
Approximately 29.0% of the patients experienced a hospitalization in 2014 (31.3% for
NHBs, 28.3% for NHWs). Among those who experienced a hospitalization, the mean
number of inpatient days was 3.9 (4.9 for NHBs, 3.6 for NHWs). Across all patients
 i.e., those with and without a hospitalization  the mean number of inpatient days
was 1.1 (1.3 for NHBs, 1.0 for NHWs).

106

Figure 5.1: Percent of patients who are NHB (top left), percent hospitalization (top
right), mean number of inpatient days among those who were hospitalized (bottom
left), and mean number of inpatients days in the entire sample comprising hospitalized and non-hospitalized patients (bottom right)

5.5.2 Analysis and Results
We rst t a logistic propensity score model that included patient-level covariates
for age, sex, service connected disability and comorbidity burden as well as a countylevel spatial random eect.

Accounting for comorbidity burden is critical, as this

allows us to compare hospitalization patterns among patients with similar disease
prole.

We then matched patients based on the logit of the estimated propensity

score and a caliper of 0.2 times the standard deviation of the logit.
discarded

n = 2, 687

The caliper

NHB patient observations due to poor matches, thus ensuring
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a well-balanced sample. In the matched sample, 29.71% of patients (NHB: 30.5%,
NHW: 28.9%) experienced a hospitalization. Among those hospitalized, the mean
number of inpatient days was 4.0; across the entire matched sample, the mean number
of inpatient days was 1.2 days (range: 0 to 86 days).

While NHB patients in the

original sample were, on average, younger, had a greater service connected disability,
were more likely to be female, and experienced a greater comorbidity burden, we saw
balance across these patient features in the matched sample.

Figure 5.2: Spatial distribution (percent of racial group living in the county) between
NHB and NHW veterans in unmatched (top row), and spatially matched (bottom
row) samples
.

Figure 5.2 displays the spatial distribution of NHB and NHW veterans in the
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unmatched and spatially matched samples.

The spatial distribution of NHB and

NHW veterans varied in the unmatched sample, implying that NHBs and NHWs
were concentrated in dierent areas. While a high percent of both NHB and NHW
veterans live in urban areas such as Atlanta, NHW veterans alone appear to be
concentrated in northern Georgia, where only 0.00% to 0.03% of NHB veterans reside
(lightest shade on the map). This spatial imbalance was eliminated once a spatially
matched sample is created. In the spatially matched sample, the distribution of NHW
veterans (the controls) more closely mimics the nearly unchanged distribution of
NHB veterans (the treated), indicating that we have selected geographically wellmatched controls.
Once a well-balanced sample was constructed, we t the spatial negative binomial
hurdle model with the same patient-level covariates and a spatial random eect.
We then used the estimated coecients from the two parts of the model to form a
standardized estimate of the dierence in the risk of hospitalization, the mean number
of inpatient days among patients with a hospitalization, and the mean number of
inpatient days across all patients.

The reported 95% CrI was constructed using

the 2.5 and 97.5 percentiles of the sample distribution of risk and mean dierences.
Estimates of the three ATTs are reported in Table 5.2. Negative estimates indicate
that NHB veterans have a lower probability of hospitalization or mean number of
inpatient days while positive estimates indicate the opposite.
The results in Table 5.2 indicate that the dierence in the risk of hospitalization
between NHB and NHW patients is

1.5 percentage points, with NHB patients having

a lower risk of experiencing a hospitalization (-0.015, 95% CrI = [-0.028, -0.001]).
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Table 5.2: Estimated ATTs in the racial disparity of the risk of hospitalization (∆1 ),
mean number of inpatient days among those hospitalized (∆2 ), and mean number of
inpatient days across the entire patient population (hospitalized and non-hospitalized
patients) (∆3 )

ATT

Estimate

95% CrI

∆1
∆2
∆3

-0.015

(-0.028, -0.001)

0.431

(-0.214, 1.138)

0.112

(-0.219, 0.476)

Conversely, NHB patients who are hospitalized spend on average approximately one
half day longer in the hospital than NHW patients (0.431 days, 95% CrI = [-0.214,
1.138]). While the 95% posterior interval does include 0, the posterior probability
that

∆2 >0 was 0.84, providing moderate evidence of an increase in the mean number

of inpatient days for NHB veterans.

Lastly, we observe a slight increase in the

mean number of inpatient days among NHBs compared to NHWs across the entire
population, i.e. those who were and were not hospitalized (0.112 days, 95% CrI =
[-0.219, 0.476]).
In a similar analysis that excluded spatial random eects, we observed a notable
dierence in the estimate of the mean number of inpatient days among those who
had been hospitalized: the estimated ATT was 0.678 days (95% CrI = [0.187, 1.200].
Thus, ignoring geographic confounding would result in a potentially misleading estimate suggesting that hospitalized NHB veterans have a large, highly signicant
increase in length of stay compared to their NHW counterparts.

This result em-

phasizes the need to control for geographic confounding and indicates that part of
the racial disparity in the number of inpatient days observed in the literature can
be attributed to racial minorities living in areas with facilities that have dierential
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hospitalization patterns in comparison to facilities in predominantly white areas.

5.6 Discussion
We have combined recent work in spatial propensity score matching and spatial hurdle models for hierarchical data to understand racial dierences in hospitalization and
inpatient days. To conduct this type of analysis, we utilized spatial random eects in
the propensity score and outcome models to account for spatial variation due to potential unmeasured geographic confounders. The spatial eects were assigned CAR
priors that promote local spatial smoothing to improve small-area estimation. We
performed this work within the Bayesian modeling framework in R-INLA, software
that is free and readily accessible to researchers.
In simulation, we explored the impact of tting only the outcome portion of the
analysis versus two-stage propensity score and outcome modeling in the presence
of unknown geographic confounding.

We observed favorable performance of the

two-stage modeling across the estimation of the three ATTs: the risk dierence in
hospitalization, the mean number of inpatient days among those hospitalized, and
the mean number of inpatient days overall.

The analysis that included only an

outcome model performed particularly poorly in the estimation of the mean number
of inpatient days.

These results indicate that rst using spatial propensity score

matching to create a balanced sample and then tting a spatial hurdle model for
the outcome is a reasonable approach when true geographic confounders may be
unmeasured or unknown.
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Our application study explored racial dierences in hospitalization and inpatient
days among a sample of diabetic veterans residing in the southeastern United States.
We achieved both patient-level covariate balance and spatial balance in the matched
sample and proceeded with the spatial hurdle outcome model to estimate the three
ATTs of interest. The small but statistically signicant estimate for the risk dierence in hospitalization between NHBs and NHWs indicated that after accounting for
patients characteristics and geographic residence, NHB patients may be less likely to
be hospitalized. While the estimate for the mean dierence in inpatient days among
those who were hospitalized was not statistically signicant, potentially related to
the small sample size of hospitalized individuals, it did suggest that hospitalized NHB
patients on average spend a half day longer in the hospital compared to hospitalized
NHW patients. However, ignoring geographic confounding would have led to a potential overestimate of the disparity. These results could have implications in cost
and patient wellness.

Future interventions may target barriers to patient-provider

communication concerning hospitalizations or aim to identify regions with issues in
inpatient resource access due to limited facilities or workforce.

Clinical programs

that target disease management and outpatient treatment should be inclusive of
racial minorities in order to achieve goals of reducing hospitalizations and extended
inpatient stays among a chronic disease population such as type 2 diabetics.
Future work might explore longitudinal trends in hospitalization and inpatient
stays between NHB and NHW patients. Additionally, as this work is restricted to
hospitalizations within the VHA, additional database resources may be explored to
understand racial dierences among the broader patient population who may be
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receiving inpatient care, namely emergency or trauma care, at local or specialized
hospitals outside of the VHA.
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Chapter 6
Conclusions of Research
6.1 Summary
In summary, this dissertation has proposed methodology to address geographic confounding, which occurs when measured or unmeasured confounding factors vary spatially, through the augmentation of the propensity score model with a spatial random eect. This work has proposed methods in both propensity score weighting and
propensity score matching. In simulation, it has been shown that ignoring space in
the presence of true geographic confounding has detrimental eects on bias, RMSE
and coverage. Furthermore, in the case of propensity score matching, tting a spatial
outcome model in addition to a spatial propensity score model improves estimation
of the ATT while tting a spatial propensity score model in addition to a spatial
outcome model achieves better estimates and coverage in the presence of unknown
spatial confounders compared to a spatial outcome model alone. This work has been
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applied to a diabetic cohort of veterans receiving care within the VHA in scal year
2014.

In the application studies, we have analyzed the eect of race on glycemic

control, diabetes education and care, and hospitalization practices.

We have seen

that addressing geographic confounding can result in a reduction or amplication
of the estimate of a disparity and that conducting spatial propensity score analysis
can elucidate information about disparities that traditional propensity score analysis
would miss.

6.2 Implications
This research provides a meaningful intersection of recent work in multilevel propensity score analysis and spatial propensity score analysis.

It allows researchers to

address geographic confounding while preserving patient-level data.

Additionally,

it complements existing methods in exploratory spatial data analysis and allows an
analyst to construct a global, minimally biased eect estimate of interest.

With

proper elucidation regarding the complexities and nuances, the proposed methodology can be applied to studies across a spectrum of public health issues, namely:
racial disparities, spatially varying exposures, and program evaluation.

6.3 Limitations and Extensions
While this research aims to address confounding that occurs due to geographic differences, it is not intended to promote geographic relocation as a solution to narrow
dierences between exposed and unexposed groups of individuals; rather, it provides
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indication that targeting geographic regions of need may be benecial and can complement eorts to target vulnerable exposure groups. It is fair to recognize that geographic boundaries are often arbitrary and may not represent ideal or homogeneous
regions of comparison. Lastly, it has been noted that dierences between individuals
reporting a county of residence and those for whom this information is missing may
be present and should be explored, especially when making generalizations from the
results of studies that require geographic information as inclusion criteria. This work
can be extended to space-time outcome models or space-by-exposure interactions.
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